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Abstract 
Design and Fabrication of Biomedical Platform Technologies for 
Improved Diagnostic Performance 
Brian O’Reilly 
Point-of-care diagnostics and therapeutics have the potential to radically change and 
improve the way disease and illness are detected and managed. This can be achieved 
by empowering the patient with rapid, real time information. Point of care testing 
also has the potential to alleviate some of the burden on crippled health care 
systems worldwide. Furthermore, personalised point-of-care testing can give more 
tailored and specific feedback to the end user. In this body of work, a novel single 
cell analysis system for antibody discovery and an integrated personalised point-of-
care platform is presented.  
In the first instance key challenges in the development of a novel single cell analysis 
antibody selection platform were addressed. This Direct Clone Analysis and 
Selection (DiCAST) Technology incorporates a highly ordered array of glass micro-
capillaries of 20 µm diameter. The first key challenge was to identify a single target 
micro-capillary of interest, containing the single antibody secreting cell of interest, 
among ≈ 1,000,000 other identical capillaries and cells. To achieve this, the ability to 
map assay patterns from the micro-capillary array to the master array containing 
the target cell was critical. Similar to where X marks the spot on a treasure map, 
micro-capillaries in a predefined pattern and orientation were blocked permanently 
using photolithography providing a reference stamp for alignment.  These blocked 
capillaries provided a reference point upon the array, giving both spatial reference 
and orientation, allowing the cell recovery hardware to locate the micro-capillaries 
required to be evacuated.  
Following the successful mapping of the array of micro capillaries the recovery of 
the contents of the micro-capillaries proved elusive. Here a system for the recovery 
of single cells from a micro-capillary was developed. Initially investigated was a 
method whereby a micro-jet of air, passed through a nozzle equal in diameter to the 
micro-capillary, for the removal of its contents.  With limited success it was 
demonstrated that, while single micro-capillaries could be interrogated and the 
contents removed, the successful and controlled recovery of the contents was 
inconclusive. Subsequently, a liquid recovery system was investigated. By coupling 
both ends of the micro-capillary with a glass capillary of similar internal diameter, 
and by flowing a buffer solution through the capillary, recovery of the contents of a 
single micro-capillary was demonstrated.  
In a second body of work, a method for cellular fraction extraction using an active 
trapping (CLEAR) approach was developed. CLEAR separates plasma from a whole 
blood sample in <10 min by removing the red and white blood cells to give 
improved signal to noise ratio during a subsequent fluorescence measurement of 
the on chip assay. Designed for point-of-care applications, CLEAR requires no 
external actuation relying on degas driven flow, together with cell gravitational 
sedimentation in a trench to separate the sample, removing the need for pumps, 
tubing, extra power sources etc. CLEAR removes the likelihood of cell re-suspension 
by actively sequestering those cells to a separate reservoir on chip. As a result, 
CLEAR could be used to analyse the cellular constituents post separation, to screen 
xii 
for e.g. cell health or cell counting.  The CLEAR concept was demonstrated using a 
fluorescence-based sandwich assay for the cardiac marker C-reactive protein (CRP). 
The research presented in this thesis describes the initial development of two key 
biomedical platforms that if combined has the potential for improved point of care 
testing. Using the research described herein as a corner stone for future follow on 
development and validation, it is envisaged that best in class antibodies selected 
using the novel DiCAST antibody discovery platform could be applied in a 
fluorescence-based assay on a whole blood sample using the CLEAR microfluidic 
chip platform for improved cardiac diagnosis at the point of patient need. 
 
Chapter I  
Introduction and Background 
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1.1 Introduction  
More recent developments in Point of Care Diagnostics (POC) means that 
remote monitoring and maintenance of disease states is enabled, thus, providing the 
patient with rapid, near-patient test results. Removing the skilled laboratory worker 
and using samples that require little or no preparation by the user or patient, point-of-
care can provide relief for overcrowded healthcare systems in developed countries and 
lead to early detection of certain biomarkers linked to various non-communicable 
disease states. This may allow for early detection and treatment and therefore 
prevention of disease progression while removing costly laboratory based tests. With 
advances in wireless communications, results obtained remotely can quickly be 
delivered to a physician to be interpreted. Frequency of testing may also be improved 
providing better trend analysis, resulting in better understanding of disease 
progression or dosage effects in the case of therapeutics. Together with advances in 
manufacturing, where disposable test kits can be manufactured at low cost, point of 
care diagnostics has potential to revolutionise the way health care is delivered.  
Split into two strands, this work contributed to two Enterprise Ireland/Science 
Foundation Ireland commercialisation projects carried out in DCU. Led by Dr Paul 
Leonard, the first section of this work relates to the development of a novel single cell 
antibody selection tool (Fitzgerald et al. 2015). By segregating individual antibody 
secreting cells and screening each cell for a specific antigen, this new technology aims 
to provide a high throughput, highly selective antibody selection tool. Part of this work 
describes some of the roadblocks encountered in developing this technology and the 
solutions realised using microfabrication techniques.  
The second body of work describes the development of an integrated 
microfluidic platform for separation of blood into its cellular components and plasma 
while also performing fluorescence based assay that could be used for a wide range of 
diagnostic applications from detection of cardiac markers to infectious disease. 
Building on work previously developed at the Biomedical Diagnostic Institute (BDI) 
(Dimov et al. 2011), an improved platform is described where cellular components are 
removed from a whole blood sample and the resulting biomarker rich plasma is 
screened for particular indicators of inflammation or disease. As part of an Enterprise 
Ireland commercialisation fund, the platform described was designed to be 
incorporated into a smart phone based point-of-care device for monitoring biomarkers 
of inflammation.  
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1.2 Antibody Generation 
There are an abundance of micro-organisms, or proteins known as pathogens, 
present in our environments and humans are exposed to them constantly. Pathogens 
fall into four general categories: viruses, bacteria, fungi and parasites. Once these 
pathogens are detected in our bodies, an individual with a well-functioning and strong 
immune system, will illicit an immune response to the particular pathogen (Murphy et 
al. 2008). Plasma cells of the immune system, upon detection of “foreign” proteins, 
generate the antibodies that bind these proteins and recruit other cells and molecules 
to destroy them. The proteins which bind to the antibody are known as antigens, which 
stimulate antibody generation, hence their name (Murphy et al. 2008). This process 
forms the adaptive immune response and is responsible for longer term immunity. It 
differs from the innate immune response which is non-specific and is the immediate 
response to any pathogens present (Conroy et al. 2009). Once presented with a 
pathogen, the naïve T cell becomes activated and transforms into an effector T cell. As a 
result, T cells proliferate and differentiate, and cytokines are released. The released 
cytokines activate naïve B cells, which then differentiate into plasma cells and memory 
B cells. Memory B cells produce the antigen specific antibody which is used in any 
subsequent immune response (Murphy et al. 2008).   
1.2.1 Antibody Structure 
Antibodies are a large protein molecule (150kDa) oriented roughly in a Y-
shape. The Y-shape is made up of a stem, and two branches which are equal in size with 
all three sections connected by flexible disulphide bonds (Murphy, Kenneth; Janeway, 
Charles; Walport, Mark; Travers 2012). The structure can be further broken into heavy 
(50 kDa) and light (25 kDa) chains, with each heavy chain consisting of three constant 
regions and one variable region. The light chain is made up with one constant and one 
variable region.(Buss et al. 2012) The variable region is located at the top of the Y 
branches comprising of the top heavy and light chains which binds the specific antigens 
(Zeng et al. 2012; Conroy et al. 2009). Due to the Y-shaped structure, antibodies have 
the ability to bind two antigens at once, which increases the antibodies avidity (Murphy 
et al. 2008). The antibody can then be further subdivided into two fragments. The Fab 
region consists of the branches of the Y-shape structure. The Fab is the antigen binding 
portion of the antibody, or Fragment Antigen Binding (Fab). This portion can be 
cleaved from the antibody, with its smaller size (25 kDa) proving useful for penetration 
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into tissue. The Fc region or Fragment Crystalizable region is cleaved from the stem of 
the Y-structure. The Fc region is responsible for effector function of the antibody. Single 
chain variable fragments or ScFv are also a common useful form of antibody. The ScFv 
is comprised of the both branches of the antibody but just includes the variable heavy 
and variable light chains of the antigen binding site. The two branches are bound 
together with a peptide linker.  
1.2.2 Types of Antibodies  
Antibodies are available in three as monoclonal, polyclonal and recombinant. 
Monoclonal (MAbs) and polyclonal (PAbs) antibodies are produced by eliciting an 
immune response in a host animal with a specific antigen. When fused with a myeloma 
cell, MAbs become homogenous and monospecific to that myeloma resulting in MAbs 
being extremely valuable research tools (Tansey & Catterall 1994). In contrast PAbs 
are heterogenous in nature and may bind to multiple epitopes of the antigen. This can 
result in lower specificity but less susceptible to antigen conformational change and 
changes in pH (Lipman et al. 2005). Recombinant antibodies are engineered in-vitro 
following the development of DNA technology. By engineering the antibody it has been 
possible to reduce its size, “arm” the antibody with a toxic payload which it would 
deliver to the antigen cell of interest and even fuse radio isotopes to the antibody for 
tracking treatment (Carter 2001; Hudson & Souriau 2003). 
1.3 Targeted Antibody Therapeutics 
Over 100 years has passed since Paul Ehrlich suggested that one day there 
would be a “magic bullet” solution to specifically target disease causing pathogens 
(Weiner et al. 2010; Adams & Weiner 2005). It is only since the discovery of 
monoclonal antibodies in 1975, by Kohler and Milstein, that the real value of targeted 
therapies has been realized (KÖHLER & MILSTEIN 1975). Even with this breakthrough, 
development of products for human therapeutics was not fully realized until the late 
1980’s. This was due to the murine origin of these MAbs, which were immunogenic in 
human subjects, inducing an immune response as a result (Weiner et al. 2010; Buss et 
al. 2012). In more recent years, MAbs are established as targeted therapies for many 
applications e.g. malignancies, autoimmune disease and transplant rejection(Lu et al. 
2012; Hansel et al. 2010).  
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1.4 Antibody Analysis and Selection Technologies 
Over the past 35 years, hybridoma technology has enhanced our ability to 
detect and quantify target molecules in cells using monoclonal antibodies (Bradbury, 
Sidhu et al. 2011). Since then, other methods have been developed to replicate the 
immune response (Love, Ronan et al. 2006, Jin, Ozawa et al. 2009, Reddy, Ge et al. 
2010) which allow us to screen increasing numbers of antibody producing cells. In 
vitro display technologies have also been refined and show great promise in their 
ability to permit more control over the nature of the derived antibody in comparison to 
immunization. In fact, many of the antibodies derived using in vitro display methods 
have properties that would be difficult to obtain using animal immunization (Bradbury, 
Sidhu et al. 2011). Current selection technologies try to mimic or replicate a similar 
response to that of the immune system, where a library of antibodies is exposed to the 
antigen of interest. The antibodies then compete to bind with that antigen. The 
competitive nature of such techniques relies upon the affinity of the antigen/antibody 
interaction and can limit the specificity of selection (Mao, Graziano et al. 2010). As 
further developments in animal immunization techniques are expected to be minimal, 
in vitro methods have the unique potential to improve antibody screening. Importantly, 
a body of the literature suggests that a high proportion of commercially available 
antibodies demonstrate poor specificity and some even fail to recognize their targets at 
all (Spicer, Spivey et al. 1994, Saper 2005, Pozner-Moulis, Cregger et al. 2007, Grimsey, 
Goodfellow et al. 2008, Jensen, Swigart et al. 2009, Jositsch, Papadakis et al. 2009, 
Bordeaux, Welsh et al. 2010). Considering modern biology depends on the quality and 
fidelity of commercially available antibodies, this highlights the need for robust 
techniques to improve antibody quality (Bradbury, Sidhu et al. 2011). In vitro display 
technologies, best represented by phage and yeast display, have the capability of 
synthesizing tailor-made antibodies which can be used to acquire the desired affinity of 
binding and specificity for both in vitro and in vivo diagnosis and immunotherapy for 
human disease (Hoogenboom, de Bruıne et al. 1998). 
Current selection technologies try to mimic or replicate a similar response to that of the 
immune system, where a library of antibodies is exposed to the antigen of interest. The 
antibodies then compete to bind with that antigen. The competitive nature of such 
techniques relies upon the affinity of the antigen/antibody interaction and can limit the 
specificity of selection(Mao et al. 2010). 
Chapter I: Introduction and Background 
6 
1.4.1 Current Selection Technologies 
Phage display allows the identification of antibodies targeting a certain antigen from a 
large antibody repertoire or library. Phage display has been reported since 1985 and 
involves the binding of an antibody to a filamentous bacteriophage(George P. Smith 
1985). Libraries with millions or potentially billions of antibodies may be screened by 
attaching to a phage molecule. The bound ligand or protein is presented on the surface 
of the phage, while its genetic material is stored within the phage. When presented to 
the target, suitable proteins on the surface of the phage bind to the target. Unbound or 
nonspecific protein and phage are washed away, while the bound phage is retained and 
analysed for specificity and affinity. This cycle is repeated until the most suitable 
antibody remains (Hoogenboom et al. 1998).  
 
 
Figure 1.1 Phage display diagram 
(Hoogenboom et al. 1998) 
Despite its continuing popularity antibody phage display is a very complex and time 
consuming technique. Due to the screening of ~10-8  antibodies from large libraries 
some lower affinity antibodies can be overlooked (Hammers & Stanley 2014) 
Using a similar technique to phage display, yeast display is another popular method for 
screening large antibody libraries. First reported in 1997 by Boder and Wittrup, yeast 
display promised some improvements over the older phage technology (Boder & 
Wittrup 1997). The yeast host is a eukaryotic cell and as a result can mimic the way the 
antibody is displayed as it might be with a mammalian cell (Sheehan & Marasco 2015). 
Yeast display has been reported to increase affinity and specificity as a result of the 
eukaryotic host (Gai & Wittrup 2007). Fluorescence activated cell sorting (FACS), used 
in conjunction with yeast display, and offers a big advantage over phage display. FACS 
can rapidly sort cells tagged with a fluorescent label from a large library of cells. Upon 
identifying the fluorescent label, the cell stream is subjected to a high voltage which 
deflects the cell of interest to a different collection vessel.  
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Direct Clone Analysis and Selection technology (DiCAST) is a patented antibody 
discovery technology that is applicable to screening both bacterial and mammalian 
antibody secreting cells (ASCs). The development of DiCAST was driven by the need for 
optimal antibody detection technology reducing time and cost for their discovery as 
monoclonal antibodies are now the largest class of biological drug with up to 30 
monoclonal antibody drugs approved by the FDA (Morrow Jr and Das 2013). An 
obvious obstacle in monoclonal drug development is how to find the monoclonal 
antibody with targeted and therapeutic properties from such diverse libraries of 
billions of potential candidates (Fitzgerald, Manning et al. 2014). Many microtools have 
demonstrated the discovery of antigen-specific ASCs. Such methods include micro 
engraving of miniature wells (Love, Ronan et al. 2006, Ogunniyi, Story et al. 2009), 
etched fibres (Biran and Walt 2002), homogenous cell spot assay (Jin, Ozawa et al. 
2009) and microfluidic cell sorting (Wheeler, Throndset et al. 2003, Singhal, Haynes et 
al. 2010, Ryan, Ren et al. 2011, El Debs, Utharala et al. 2012). However, these methods 
pose certain limitations. They are generally not applicable to both bacterial and 
mammalian screening. They offer limited multiplexed capabilities and relating to 
spatially addressed techniques they are limited in cell number capacity (105 cells per 
experiment) (Fitzgerald, Manning et al. 2014). DiCAST, however, is a new and novel 
microtool built for the identification of antigen specific monoclonal antibodies from 
millions of individual bacterial and mammalian cells in picolitre to nanolitre 
bioincubation chambers.  
DiCAST is a new microtool developed to identify antigen specific monoclonal antibodies 
from millions of individual bacterial and mammalian cells in picolitre to nanolitre 
bioincubation chambers using commercially available capillary plates of densely 
packed micro-capillary flow-through arrays. These flow-through plates are 
advantageous in that they utilize an advanced glass drawing technology in order to 
produce hollow arrays in a range of cross sections, pore sizes and lengths providing 
over 0.95 million assay chambers when using densely packed 40 µM diameter hollow 
capillaries placed on a chip the size of a standard microscope slide. Another unique 
aspect of these capillaries is that they possess an open top and bottom which allows for 
the dual detection surfaces for antigen specific monoclonal antibodies can bind. This 
process allows us to analyze cells captured and cultured in micro capillaries which are 
sealed at one or both ends by an antigen coated plate, which in itself is a removable 
assay surface for each capillary. These surfaces can be washed and if any specific 
antibody is bound to the antigen surface, it can be detected using fluorescence. The 
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fluorescent spots which correspond to a positive signal can then be mapped to the 
micro-capillary array which contains the ASC which is required to be cloned. The image 
pixel coordinates allows for specific identification of the capillary that contains the 
single cell producing the antibody to the target of interest. Individual cells are 
recovered into 384 well microtiter plates using high precision alignment whereby the 
contents of the capillary of interest are recovered by flowing nitrogen through a hole to 
simply blow out the contents into a well of a 384 well plate located just beneath the 
capillary array, recovering one cell every 3 seconds using the DiCAST custom LabView 
software (Fitzgerald, Manning et al. 2014).  
The existing technologies are unable to directly screen libraries of antibody secreting 
cells consisting of millions to billions of individual cells. Therefore, it may prove 
beneficial to utilize selection rounds based on enrichment by biopanning or cloning by 
limiting dilution, prior to direct cell analysis. With this in mind, DiCAST provides us 
with a direct cell screening and analysis platform of both bacterial and mammalian 
libraries with little need for enrichment on the antibody discovery phase. Therefore, it 
is suggested that a number of aspects of the DiCAST technology do have advantages 
over other more traditional methods with regard to monoclonal antibody discovery. 
For instances, the open ended and densely packed micro capillary array allows DiCAST 
to provide up to 10 – 1000 times more analysis chambers per chip compared in 
comparison to other well based assays (Love, Ronan et al. 2006, Ogunniyi, Story et al. 
2009, Sendra, Lie et al. 2013). Another unique feature of this method is that it has two 
open ended assay surface allowing for a dual surface exposure and analysis. This open 
capillary system allows for precise and quick automated recovery of the capillary 
contents every three seconds using pneumatic based pressure. DiCAST is more 
dynamic in that it can identify antibody secreting cells from both mammalian and 
bacterial libraries which requires less time and less resources in comparison to current 
commonly used methods. Therefore, cell based screening using micro tools allows for 
real time characterization of individual antibody secreting cells. DiCAST is presented in 
this thesis as a novel and more advanced technology for single cell analysis. 
1.5 Single Cell Analysis  
Single cell analysis is a powerful tool that allows the differentiation of individual or 
select cells from heterogeneous populations. By analysing cells individually greatly 
reduces noise in the process, and allows for example the differentiation of cancer cells 
from a normal cell population by looking at mitochondrial mutations in DNA or in the 
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case of stem cell research, the differentiation of embryonic and adult stem cells (Wang 
& Bodovitz 2010).   
Flow cytometry for example, is regarded as the mainstay for high throughput single cell 
analysis for many years. As a technology it is limited by instrumentation complexity 
and cost (Lecault et al. 2012) and by observing the cell in isolation, does not capture 
the innate cellular response. Recent advances in imaging technology are allowing real 
time observation of cell interactions in their natural environment, but these 
developments are limited in their throughput (Yin & Marshall 2012a). With imaging 
techniques, any subsequent manipulation of the cells identified may require the use of 
micro-tools such as a micromanipulator. Developed in the early 20th century  
micromanipulators have advanced hugely since but still require great skill and 
dexterity to operate while also being very low throughput (Barer & Saunders-Singer 
1948). Optical tweezers are emerging as a useful tool for manipulating object in a 
precise and non-contact fashion. First reported in 1986 as purely a method of 
manipulating of small dielectric particles in water, optical tweezers have been 
developed to trap, manipulate, detect and measure biochemical materials (Moffitt et al. 
2008; Burger et al. 2015). Again this technique is limited instrumentation complexity, 
cost and low throughput. It seems microfluidics possible applications are limitless, with 
single cell analysis emerging as a leading application. Described as “total analysis”, 
microfluidics promises to be able to deliver analysis from the cell live state to cell death 
on one platform. However, this requires the complex fabrication of micron scale 
geometries typically in a polymer substrate, delivery of, and possibly incorporation of 
reagents within the channels along with a detection method to obtain a result. All those 
considerations need to be addressed before the recovery of the single cell that has just 
been analysed is recovered (Yin & Marshall 2012b).  
1.6 Inflammation  
The inflammatory process plays an important role in the development and 
pathogenesis of many chronic diseases such as cardiovascular disease (CVD), type 2 
diabetes, rheumatoid arthritis and metabolic syndrome. Early identification of 
metabolic biomarkers may be of great importance in order to halt the progression of 
such non-communicable diseases. Serum C-Reactive Protein (CRP) is a widely tested 
inflammatory marker. In fact, it has been widely debated whether CRP should be used 
as a predictor of first cardiovascular event. In 2010, the American College of Cardiology 
Foundation AHA Task Force on practice guidelines suggested that CRP assessment was 
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reasonable for individuals at intermediate risk of a cardiovascular risk (Greenland, 
Alpert et al. 2010) where intermediate risk qualified as having at least two 
cardiovascular risk factors. To support this, an analysis of 52 prospective cohort 
studies that included 246,669 individuals with no history of CVD, investigated the value 
of adding CRP assessment to the conventional risk factors for the prediction of a 
cardiovascular event. It was reported that adding CRP screening in people at 
intermediate risk could help prevent one additional event in every 400 out of 500 
people to be screened over a 10 year period (Collaboration 2012). The literature 
supports the early measurement and monitoring of inflammatory states and in 
particular C-reactive protein.  
1.6.1 C-Reactive Protein 
CRP was first detected in 1930 by Tillet and Frances. They identified the substance in 
serum of patients with acute infections like pneumonia (Tillett and Francis 1930) 
which indicated that the body had a chemical response to inflammatory states. This led 
to the characterization of “acute phase proteins” (Abernethy and Avery 1941). An acute 
phase protein exists in the blood and is rapidly increased or decreased in response to 
injury or trauma such as a heart attack, infection, burns or inflammation. CRP is the 
classical acute phase reactant, the circulating concentration of which increases rapidly 
in response to tissue injury and inflammation (Thompson, Pepys et al. 1999). CRP 
increases in order to enhance the inflammatory function of leucocytes that are 
responsible for removing the invading bacteria or virus. It does so by attaching to the 
invading agent inducing white blood cells or other leucocytes to attack the agent. Under 
normal conditions, CRP concentrations in blood are 10 mg/L. However, upon injury, it 
has been reported that the concentration can increase up to 1000 fold (Clyne and 
Olshaker 1999) reaching a peak concentration of 350 – 400 mg/L within 48 hours of 
injury (Clyne and Olshaker 1999). CRP elevation is stimulated by cytokines, 
particularly IL-6, IL-1 and tumor necrosis factor (Kolb-Bachofen 1991, Jupe 1996) and 
is synthesized by hepatocytes. It is a pentameric protein made up of five noncovalently 
bonded identical subunits with a molecular weight of 118 KDa. It has been suggested 
that CRP has the capacity to activate complement through the classic complement 
pathway and to modulate the actions of phagocytic cells lending to its role in 
opsonisation of infectious agents and damaged cells (Kolb-Bachofen 1991). For this 
reason, measurement of CRP has been found useful for monitoring exacerbations in 
chronic inflammatory conditions such as rheumatoid arthritis (Young, Gleeson et al. 
1991). The early quantification of CRP using point of care diagnostics could be a useful 
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tool in order for medical staff to risk assess patients and indeed for patients to monitor 
this biomarker themselves independently using microfluidic electrophoretic 
immuneassays integrated with sample preconcentration and mixing of analytes with 
fluorescently labelled antibodies (Meagher, Hatch et al. 2008).  
1.7 Point Of Care  
1.7.1 Assays 
Point-of-care (POC) testing has been defined by the College of American Pathologists as 
analytical testing performed outside the laboratory using devices that are easily 
transported to the vicinity of the patient (Pathologists 2001). By obtaining human 
biological samples such as saliva, blood urine or other bodily fluids, POC testing can 
quantify analytical targets such as proteins. The ease of obtaining a sample with little or 
no pre-preparation allows the care giver in a hospital setting or a person at home to 
easily and efficiently apply the sample and obtain an “answer” within seconds to hours 
(Meagher, Hatch et al. 2008). The more conventional bench top techniques such as 
enzymatic activity assay or ELISA are limited by expense, labour demands, time and the 
need for highly trained personnel (Meagher, Hatch et al. 2008). However, with the 
development of point of care testing, these hand held devices require uncomplicated 
instructions for use. Additionally, interpretation of test results may be as simple as 
viewing a colour change on a strip or a polymer. Another positive aspect of POC is the 
relative low cost in comparison to more conventional methods. The reading 
instruments are smaller and infact more specialized than laboratory devices. 
Additionally, the biological sample never makes contact with the instrument; hence 
there is no need for a self-cleaning system. The sample is placed on a chip or cartridge 
that is not designed for reuse. With POC testing, sample mislabelling or mishandling is 
less likely as results are provided instantly, again lowering the medical cost of sample 
processing. The time taken to administer the test and obtain the result is instant. 
However, the literature clearly suggests that speed of obtaining results must never be 
traded for accuracy or reliability (Gubala, Harris et al. 2011). While POC testing is often 
administered by a medical professional, it can also be self-administered, giving patients 
independence and forcing them to become more responsible about the management of 
their disease state and indeed more compliant to the their treatment plan. However, 
this does raise a concern regarding the lack of professional medical input and 
monitoring. It is therefore imperative that patients receive reliable devices and 
adequate training to learn how to use the device.  
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1.7.2 Point of Care Technology 
Optical detection is the leading method by which blood is analysed, dictating the 
removal of the large cellular components when trying to identify protein biomarkers. 
With the larger cellular components removed, the remaining clear plasma provides a 
better medium for detection with less noise, light scattering and non-specific 
binding(Dimov et al. 2011). The larger red blood cells, due to their shape, size and 
density have certain behaviours that can be harnessed to aid their removal. Due to their 
flat disc shape, RBC’s have been reported to tumble randomly within the flow(Shi et al. 
2012; Kersaudy-Kerhoas et al. 2009), migrate away from the vessel walls towards the 
centre of the vessel and over time sediment under their density and weight(Sun et al. 
2012; Bernate et al. 2013). Individually or collectively these characteristics can be 
exploited by microfluidic platforms to effectively separate the cellular components 
from a whole blood sample.  
The devices used should be inexpensive disposable chips which have a microfluidic 
feature to control sample preparation, flow rate, mixing with reagents, reaction time 
associated with binding of antibodies and filtration of the samples which obtaining an 
effective measurement (Gubala, Harris et al. 2011).   
1.7.3 Microfluidics and Point Of Care 
From its origins in gas-phase (GC) and high-pressure liquid (HPLC) chromatography, 
microfluidics has many different application areas as alluded to earlier in this thesis. 
Driven also by advances in the semiconductor industry, photolithography and silicon 
were seen as an ideal platform to achieve the scale of features require to realise the 
microfluidic concept (Whitesides 2006). One of the main motivations for microfluidics 
is that of point-of- care. While accessible in the developed world, rapid and accurate 
diagnostics are not readily available in the developing world and it is thought that 
microfluidics will assist in the deployment of cheap alternatives to these impoverished 
areas. The WHO recommendation is the diagnostics for the developing world should be 
ASSURED: affordable, sensitive, specific, user-friendly, rapid and robust, equipment 
free and deliverable to end-users (Martinez et al. 2010). Microfluidics is also seen as a 
way to alleviate the already overburdened health care systems in the developed world 
by shifting ownership of testing and monitoring to either the general practitioner or the 
patient in the home (Yager et al. 2008).   
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Many pumping techniques exist for delivering the sample through the microfluidic 
channel network. Capillary force is the dominant force at the micro scale and can be 
harnessed to propel a liquid through a microchannel (Sackmann et al. 2014). Capillary 
forces are used in most lateral flow assays such as home pregnancy kits and can use 
porous materials like paper or high density micro-pillars to transport the sample 
through a device (Jönsson et al. 2008; Godino et al. 2012). Capillary force flow is seen 
as an ideal method for pumping owing to its simplicity, low cost, and no requirement 
for external power (Gubala et al. 2012). Pressure driven flow by means of peristaltic or 
syringe pumps is common in point of care research settings. Ideal for the benchtop in 
terms of programmability and control, the technique is limited by its complexity, size 
and external power requirement (Haeberle & Mark 2012). Centrifugal microfluidics 
have been reported for some time and are based on the original centrifuge technology 
(Haeberle & Mark 2012). By fabricating channels radially form the centre of a disc, the 
resulting force upon the contents of the channels force the contents towards the outer 
edge of the disc. The technology lends itself well to cell separation, capturing and 
assaying but is ultimately limited by the need for a device on which to spin the disc 
(Burger et al. 2012). Electrokinetic driven flow has been investigated as a mode of 
transport for in microfluidics since the early 1990’s, and involves inducing a large 
voltage to an electrolytic solution to propel the sample along the channel (Harrison et 
al. 1992). Electroosmosis and electrophoresis use a DC voltage source and can require a 
large voltage, up to hundreds of volts, which can adversely affect delicate samples such 
as DNA (Sin et al. 2011). AC voltages typically require <10 V and can be used as an 
alternative. AC driven flow can also perform operations such as making it more 
attractive as point of care option (Gubala et al. 2012).  
Chapter II  
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2.1 Antibody Selection Tool  
2.1.1 Micro-capillary Array Preparation 
In this section, processes and materials used to implement the novel antibody 
selection tool is described. The capillary arrays described in all the following work 
were sourced from INCOM (www.incomusa.com).All arrays used consisted of 40 µm 
diameter x1mm length capillaries, bundled together in a 23x23 mm form. This 
equated to ~260,000 capillaries within that footprint.  
2.1.1.1 Photolithography Mask Fabrication 
All masks used were fabricated in-house. This process involved the sputtering of a 
layer of gold onto a standard glass slide. The gold layer was then ablated using an 
excimer laser to generate the desired pattern.  
2.1.1.2 Gold Sputtering 
Using a Quorum K650X sputter coater (www.quorumtech.com), a 100 nm layer was 
deposited onto the surface of a standard glass slide. The layer thickness was 
controlled by the voltage applied to the target and the time allowed. The chamber 
was purged of ambient air and reduced to 1 x 10-3 mbar in order for the plasma to 
form on the gold electrode. The plasma allowed the transfer of gold from the target 
to the glass surface.  
2.1.1.3 Laser ablation 
The gold sputtered glass slides were then patterned by ablating a design realised 
using AuoCAD 2014, in the gold layer. Ablating a portion of the gold layer allowed 
the transmission of light. 
The sputtered glass slide was placed on the XY translation stage of the excimer laser. 
The AutoCad 2014 trace file was transferred to the PC connected to the laser. By 
following the path of the trace file, the laser ablated the desired pattern. The focal 
point of the laser was set by adjusting the laser head in the z-plane. To set the focal 
point the top surface of the gold layer was viewed and once it was in sharp focus the 
laser was focused. The work piece was viewed through the laser optics using a 
through the lens (TTL) system. This also allowed the laser to be aligned to specific 
points on the work piece. A 300 µm diameter aperture was used, which controls the 
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diameter of the beam applied to the surface of the work piece. By applying a 10 % 
demagnification, the resulting feature ablated on the work piece is 30 µm.  
Laser ablation was carried out using the Optec MicroMaster Excimer laser 
(www.optec.be). The excimer laser uses a 248 nm Krypto-Fluoride (KrF) laser 
source.  
The following settings were used for ablating the deposited gold layer: 
Table 1.1  Laser parameters used for ablating gold layer on glass 
Frequency 300 Hz 
No. of Shots 250 
% Transmission 70 % 
Power  10 mJ 
Speed (function of freq. vs no. of shots) 120 µm/sec 
Energy Density  875 mJ/cm2 
2.1.1.4 Polymer Mask Fabrication  
The array was covered with Scotch® Easy Tear Clear Tape. The covered array was 
then placed on the translation stage of the excimer laser. An AutoCad 2014 trace file 
was transferred to the PC connected to the laser. By following the path of the trace 
file, the laser ablated the desired pattern. Before starting to ablate a single pore was 
aligned with the laser by means of the through the lens (TTL) vision system. This 
allowed the user to view the focal point of the laser for both alignments on focal 
length relative to the workpiece. The focal point was adjusted by moving the laser 
head in the z plane until the top surface of the work piece i.e. the scotch tape upon 
the array was in sharp focus.  
Ablating the Scotch tape however required different laser parameters, as detailed in 
Table 1.2 below. More power was required to ablate ~50µm thick polymer scotch 
tape compared to the 100 nm gold layer. In this case the aperture used was 750 µm 
in diameter, resulting in 75 µm features ablated on the surface.  
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Table 1.2 Laser parameters used for ablating Scotch tape on glass 
Frequency 300 Hz 
No. of Shots 400 
% Transmission 80 % 
Power  20 mJ (max) 
Speed (function of freq. vs no. of shots) 56 µm/sec 
Energy Density  2715 mJ/cm2 
The extra energy, shots and % transmission produce an overall greater energy 
density to ablate the thicker layer.  
2.1.1.5 Photoresist Application 
The photo resist used for this application was SU8 3010 by MicroChem Corp., USA. 
SU8 3010 is specified for features of 10–20 µm. It’s low viscosity allowed 
penetration into the 40 µm capillaries. SU8 3010 is a negative photoresist, where UV 
exposure cures the epoxy bonding it to the glass surface with which it is contact.  
Before applying the photoresist to the array, the array was sealed to a slab of PDMS. 
The PDMS was degassed prior to the array being applied. The PDMS was utilised to 
draw the photoresist into the micro-capillaries an also while sealing the bottom side 
of the array; prevent photoresist from leaking onto the underside of the array.  
Once sealed to the PDMS, photoresist was applied to the array in each of the four 
corners. For the photo mask approach, the photoresist was applied to the positions 
that corresponded to the mask. With the polymer mask the location was defined by 
where the scotch tape was ablated.  
Photomask: 
Here the photomask was applied directly to the uncured SU8 upon the array. As a 
consequence of the contact with the uncured SU8, the masks were not reusable. The 
photo mask made contact with the array to reduce the divergence of the UV light as 
it passed through the mask.  
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Polymer Mask:  
The scotch tape mask covered the entire array except the portion above the 
capillaries that were required to be modified. Holes were ablated in the tape as 
described above to allow the photoresist penetrate the capillaries required. 
2.1.2 Alignment Patterning 
The following procedure describes the steps involved in transferring the patterns 
applied to the array in Section 2.1.1 to a PDMS surface for analysis. For this, firstly 
the PDMS surface is coated with the hIgG antigen. Following incubation and blocking 
steps, fluorescently labelled α-hIgG is added to the array around the alignment 
marks. If the marks were successfully applied the α-hIgG will not penetrate the 
capillaries intended to be blocked and transfer that pattern to the PDMS surface.  
2.1.2.1 PDMS preparation and Alignment Transfer Procedure  
A 5 mm slab of PDSM was prepared using a 10:1 mixture ratio of polymer to curing 
agent by placing a thin PDMS layer (what company) onto a thick PDMS slab. This 
thicker slab provides more suction to draw liquid through the array. The surface of 
the thin PDMS was covered with 5µg/ml hIgG in 2 ml 1xPBS and incubated at room 
temperature for 1 hour.  Using a Gilson pipette, the hIgG was carefully removed. The 
surface was incubated in a blocking solution using 3% BSA in 1x PBS and incubated 
for 1 hour at room temperature. The surface was then gently washed using 1X PBS 
and allowed to air dry. Any air bubbles present were removed following 30-60 
minutes of vacuum degassing. 7.5ul of α-hIgG (1:6000 dilution in 3% BSA) was 
applied to each alignment mark and entered the capillaries. In one fluid motion, the 
array was then sealed to the PDMS. A change in colour of the array/PDMS contact 
surface was noted and ensured the array was sealed. After 1 hour incubation at 
room temperature, the array was removed from the PDMS. The PDMS was washed 
with 1X PBS and allowed to air dry.  
2.1.2.2 PDMS Scanning and Analysis 
Once the PDMS has been allowed to dry it was scanned to image the transferred 
pattern. The thin PDMS layer was removed from the thicker PDMS slab. The thin 
layer was then applied to a glass coverslip. Another glass coverslip was applied on 
top of the patterned surface, sandwiching the PDMS between them. The coverslips 
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provide a rigid support for the PDMS and its introduction into the Perkin Elmer 
ScanArray GX.  
The Perkin Elmer scans the surface of the PDMS by traversing the 25 mm width of 
the PDMS in 5 µm increments. This increment produces a 5 µm resolution image of 
PDMS surface.   
2.2 Micro-Air Jet Fabrication  
The micro-air jet concept was realised by casting PDMS around a tungsten wire. The 
tungsten wire (Goodfellow Cambridge Ltd., part # W005130) was 25 µm in 
diameters and formed the inner diameter of the micro-air jet.  
An outer housing was fabricated using a lathe. The housing was formed using 20 
mm aluminium bar. Using the design described in Figure 2.1, the aluminium bar was 
machined to the dimensions described. Once the lathe machining was complete the 
5.5 mm diameter opening at one end of the housing was threaded to R 1/4 UNF 
thread. This thread was used to couple a 6 mm pneumatic push fitting with a R 1/4 
male thread.  
Either end of the machined aluminium housing was sealed with custom made caps 
with centred guide holes for suspending the 25 µm tungsten wire. With the caps in 
place and the wire suspended through the centre of the aluminium housing, PDMS 
was poured into the housing and baked at 65° C for 6 hours.  
  
Figure 2.1 Air Jet mechanical drawing. Cap used to align tungsten wire within centre of aluminium 
sleeve also show. All dimensions in mm except thread described.  
Once cured the caps were removed. The tungsten wire was then withdrawn from 
the cured PDMS which maintained the 25 µm inner diameter. 
Guide 
hole to 
suspend 
tungsten 
wire 
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The 6mm pneumatic push fitting was then applied to the R 1/4“ threaded hole. 6 
mm tubing could then be coupled from the regulator in the lab to the micro-air jet. 
2.2.1 Experimental Rigs 
The experimental rigs were setup using standard optical tables allowing flexibility to 
modify and change the layout of the experimental components as required. Optical 
posts were used to mount parts upon. The 25 mm pitch allowed the components to 
be arranged in a modular fashion and modified easily.  
2.2.1.1 3D Printing 
As a rapid prototyping method, 3D printing was used to fabricate components which 
would otherwise be difficult and expensive to fabricate. Using this method allowed 
the in-house design and fabrication of these parts where otherwise would be 
outsourced to a third party.  
All parts were fabricated using a Stratasys UPrint SE (Stratasys Ltd., MN, USA) fused 
deposition modelling instrument. The parts were initially modelled using 
SolidWorks 2014 3D modelling software. The 3D models were converted from a 
“.prt” file to a “.stl” file. This conversion divided the model into multiple thin 
horizontal slices which were then printed one by one on top of each other. Each 
layer had a resolution of 254 µm which ultimately restricted the minimum feature 
size that could be printed. The ABS material was heated to 300 °C allowing it to be 
extruded and bond to the previous layer. The printing chamber was maintained at 
70 °C to prevent the previous layers from fully setting before the subsequent layers 
were allowed to bond.  
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Figure 2.2 Stratasys UPrint SE with a 3D model of a part with the resulting printed part as part of the 
experimental assembly. 
Once printed the part was immersed in a caustic detergent solution to dissolve any 
support material used in the process. The caustic detergent solution was also 
supplied by Stratasys Ltd. Once all support material was removed the part was 
rinsed with deionised water and was ready for use.  
2.3 Micro-Liquid Jet Fabrication  
The micro-liquid jet was designed by coupling a thick walled glass capillary to an 
aluminium sleeve. The capillary was coupled via the aluminium sleeve to HPLC 
tubing and a gas tight syringe.  
2.3.1 Glass Capillaries 
Thick walled glass capillaries were sourced from Vitrocom Inc., NJ, USA via CM 
Scientific Ltd., UK. 3mm outer diameter capillary with inner diameters of 25, 75, 
125, and 200 µm was cut into 20 mm sections using a diamond blade cutter. The 
machine held the capillary in a y clamp which aided cutting the capillary as square 
as possible.  
After cutting the cut face was polished either end of the 20mm section. The first 
polish used a 250 µm grade polishing pad followed by a 25 µm polishing sheet. A 
small block of 10 mm thick acrylic was drilled with a 3mm hole with a friction 
tolerance to that of the outer diameter of the capillary. The capillary was held in the 
acrylic block and passed over the polishing pad to achieve a flat surface finish.  
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2.3.2 Aluminium Sleeve 
The aluminium sleeve was designed as a means to hold the fragile glass capillary 
and to couple the capillary to the gas tight syringe via HPLC tubing.  
The sleeve was machined manually using a lathe. The through hole for the capillary 
was machined to a friction fit tolerance. A thin layer of epoxy glue (Araldite) was 
applied to the outer surface of the capillary before it was inserted into the sleeve. 
With the tight tolerance a strong bond was formed with the capillary and the 
aluminium sleeve. The sleeve could then be clamped in position reducing the risk of 
breaking the glass capillary. A collar was machined on the sleeve as a means to 
position it in the experimental rig and restrict its movement.  
(a)  
 
(b) 
 
Figure 2.3 Aluminium Sleeve for liquid jet. (a) Mechanical drawing of the sleeve with physical part 
shown in image (b) 
The sleeve was threaded at one end. This allowed the HPLC fitting to connect to the 
capillary. The HPLC tubing, which is clamped using a ferrule, forms a high pressure 
seal to the glass capillary.  
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(a)
 
(b)
 
(c)
 
Figure 2.4 HPLC assembly detail. (a) shows the aluminium sleeve with green HPLC fitting in place. (b) 
CAD schematic of the assembly with (c) showing the contact point between the glass capillary and the 
HPLC tubing. The red line in (c) highlights the two surfaces in contact where the seal is formed with 
the inner diameters of both the capillary and tube aligned. (Tube and capillary inner diameters not 
drawn to scale) 
The HPLC PEEK tubing with 1/16" outer diameter and 0.010" inner diameter from 
IDEX Corp., US is coupled to the capillary using HPLC flanged fittings. The flange 
clamps and seal the tubing forming a high pressure seal between the nut shown in 
Figure 2.4 (above in green) and the surface which the nut is tightening against. In 
this case the glass capillary is acting as the surface to which the HPLC flange is 
tightening. The flange and the nut maintain the tube in a concentric position within 
the threaded hole also, keeping it aligned with the inner diameter of the glass 
capillary.  
2.4 Blood Separation Platform 
Blood separation was carried out with in-house designed and fabricated 
microfluidic platforms.  
2.4.1 Microfluidic Chip Fabrication 
The microfluidic chips were fabricated by using a double sided adhesive tape 
supplied by Ahesives Research Inc. The product, ARcare 92712 with dimensions 48 
µm (± 2 µm) in height was cut using a Graphtec RoboMaster PRO. The Graphtec 
instrument is knife cutter from Graphtec GB. Designs drawn with AutoCAD 2014 
were traced with the knife to produce the required channel features.  
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2.4.2 Soft Lithography  
To create the master around which the Sylgard 183 PDMS was moulded to form the 
microfluidic structures, a layer of ARcare 92712 was applied to a polystyrene petri 
dish. ARcare 92712 is a double sided adhesive tape and is structured with two 
protective liners on either side of the double sided tape. 
The top release liner and the double sided tape were cut only at this point. The 
bottom release liner was not cut, thus acted as a support for the features of < 1 mm 
which were cut. The tape was cut using a Graphtec RoboMaster PRO knife cutter 
from Graphtec GB, using designs drawn with AutoCAD.  
To start the petri dish was wiped down using paper towel soaked in ethanol. The 
double sided tape was applied to the bottom of the petri dish. The trench, described 
in Section 2.4.3 was applied to the trench portion of the double sided tape. Pressure 
was applied to the trench to ensure adhesion to the tape.  
The top plate to carry the upper channels of the microfluidic chip was also wiped 
clean with ethanol soaked paper towel. This top plate was cut from a 3 mm sheet of 
acrylic with a diameter of 130 mm, allowing it to fit with the petri dish. When 
prepared the double sided tape to make the top channel structure was applied to the 
top plate. The top plate was then inverted and again the trench, already in place on 
the petri dish, was aligned with the double sided tape on the top plate. Pressure was 
applied to the trench tape junction to ensure good adhesion. PDMS was then 
prepared and added to the dish, filling the void between the top plate and the 
bottom of the dish. 
 
Figure 2.5 Double sided mold. The trench forms the height of the part and the via from the top features 
to the bottom features 
 
40ml of PDMS was required for each petri dish. Sylgard 184 PDMS by Dow Corning 
was mixed with a 10:1 polymer to curing agent ratio. Once mixed the PDMS was 
poured into two 50 ml centrifuge tubes. The tubes were then spun at 3000rpm for 3 
minutes to remove any air bubbles from the mixture.  
Trench  Double-sided Tape  
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The PDMS was then poured into the petri dish, taking care to fill gradually from one 
side of the dish to the next and not allowing air pockets to form under the top plate.  
If any air pockets were observed the dish was placed under vacuum in a desiccator 
and allowed sufficient time to remove the unwanted air.   
With all air removed from the PDMS, and ensuring that there was sufficient PDMS in 
the dish to make contact with the entire top plate, the dish was placed in an oven 
and baked overnight at 65°C. Care was taken to ensure that the dish was placed level 
on the shelf of the oven to ensure uniform thickness post baking. 
Following baking the parts were removed from the oven and cut to 75 x 35 mm, 
with the microfluidic channels centred roughly along the 75 mm length.  
2.4.3 Trench Fabrication  
The trench was fabricated by laser cutting acrylic sheet to the desired dimensions. 
Designs were once again drawn using AutoCAD 2014 and transferred to the EPILOG 
Zing CO2 Laser.  
   
Figure 2.6 CO2 laser. Zing laser used to cut acrylic parts for trench. 
 
The trench dimensions were adjusted according to the schematic in Figure 2.7 
below. The 2 mm width was controlled by the thickness of the acrylic sheet with the 
remaining dimensions controlled by the AutoCAD design.  
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Figure 2.7 Trench configuration . Length and angle θ were adjusted. 
The EPILOG laser system was controlled by setting the power applied to the laser, 
adjusting the focal height of the laser head and the write speed of the laser head. The 
output power of the 40 W CO2 laser was expressed as a percentage ad could be 
adjusted in 1 % increments. The speed was measure in mm/sec and could be adjust 
by 0.1 mm/sec increments. The focal height from the laser head to the material was 
constant, but with different thickness of material, the machine bed required 
adjustment up and down to maintain that focal distance.  
Once cut and reclaimed from the machine bed, the trench parts were cleaned with 
95% ethanol, rinsed with deionised water and dried under a nitrogen stream.  
2.4.4 Chip Preparation  
After removal from the oven as described in Section 2.4.2, a strip of 250 µm Zeonor 
polymer sheet was prepared to seal either side of the PDMS. The Zeonor, sheet was 
supplied by Zeon Chemicals Europe Ltd., UK. 
To prepare the strip, it was first cut to the same dimensions as the PDMS, 75 x25 
mm. The strips were then prepared by firstly washing in 2% Micro90 mixed with 
deionised water. The Zeonor was sonicated in 2% Micro90 for 15 minutes. The 
strips were removed and rinsed with deionised water to remove any residual 
Micro90 detergent. The strips were then placed in 95% ethanol, also diluted with 
deionised water, and sonicated for 15 minutes. Next, the strips of Zeonor were 
removed and rinsed with deionised water and placed in a bath of fresh deionised 
water and sonicated for a further 15 minutes. Once this step was completed, the 
strips were rinse one final time and dried with a N2 stream.  
When fully dried the strips were then applied to the PDMS microfluidic chip. Care 
was taken to fully seal the channel structures with the Zeonor. The strip applied to 
2mm 
θ° 
L (mm) 
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the top layer of the PDMS was placed so that the end of the inlet channel was 
accessible for the application of the sample during experimentation. 
The microfluidic chips were then stored under vacuum in a desiccator until ready 
for use.  
2.4.4 Image and Video Capture 
All video footage of experiments was captured using a USB MicroViewer microscope 
camera. The picture was recorded in 640x480 pixels. The AVI  footage was viewed 
and analysed using VLC media player.  
Still images were all recorded with an iPhone 5S digital camera and recorded at 8-
megapixels.  
2.4.5 Blood Handling and Collection 
Blood was collected for separation experiments at the DCU Student Health Centre by 
a trained nurse and phlebotomist. 10 ml Lithium Heparin coated glass tubes were 
used for collection. Lithium heparin tubes were chosen to limit the coagulation of 
the blood before experiments.  
Samples were drawn and utilised in experiments, where possible, in less than 2 
hours to reduce the effect of coagulation and natural sedimenting of the cellular 
portion of the sample.  
Blood was only handled upon attendance at the mandatory blood handling and lab 
safety seminar provided by the BDI.  
All blood was handled at designated biohazard areas within the lab with designated 
benches for use with bio-hazard material. Designated bio-hazard pipettes with 
filtered tips were also used when handling blood. A lab coat, gloves and safety 
glasses were worn at all times in line with PPE procedures when handling blood or 
other bio-hazard substances.  
Any surplus blood sample and discarded pipette tips, consumables and microfluidic 
chips etc were initially soaked in 1% Virkon for > 12 hours before disposing. After 
soaking the Virkon solution was drained off and the waster disposed in a designated 
bio-hazard bin.  
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2.5 Immunoassay  
The following sections describe the application of an immunoassay upon the 
microfluidic platform and its verification using the gold standard lab techniques 
which were carried out upon standard 96-well plates. 
2.5.1 On-Plate Assays  
The on plate assay was carried out in two ways. Initially it was performed as a 
standard ELISA protocol. The assay was carried out as follows: 
 100 µL @ 5 µg/mL of mouse anti-human CRP-C2 capture antibody was 
added to a Nunc Maxisorp 96 well micro-titre plate (3 rows of 10) 
 The capture anti-body was incubated at 4°C overnight.  
 The plate was washed with PBST/PBS three times. 
  200 µL 3% BSA was added to the plate to block the portion of the surface 
that did not bind the capture antibody.  
 Incubated at 37°C for 1 hour.  
 After incubation the plate was washed with PBST, followed by a rinse with 
PBS three times. 
 Starting with 40 mg/L CRP in PBS, a series of 1 4⁄  dilutions were applied to 
the plate in triplicate. (Dilutions – 40, 10, 2.5, 0.625, 0.15625, 0.0390625, 
0.00976563, 0.0024414, 0.00061, 0.00015, 0) 
 The plate was again incubated at 37°C, washing again with PBST/PBS three 
times.  
 Finally the detection antibody, DY647-αCRP (2.5 µg/mL) was applied to the 
plate, 
 Incubated at 37°C for 1 hour.  
 Finally, the plate was washed once again with PBST/PBS three times, and the 
fluorescence was measured on the Tecan Infinite 200 plate reader. The 
Tecan gave a fluorescence intensity measurement for the individual wells in 
a 96 well plate.  
This standard assay was then modified to demonstrate what result might be 
expected if the assay were carried out using a microfluidic system where multiple 
washing and incubation steps were not feasible or possible. This single step protocol 
is described as follows: 
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 100 µL @ 5 µg/mL of mouse anti-human CRP-C2 capture antibody was 
added to a Nunc Maxisorp 96 well micro-titre plate (3 rows of 10) 
 The capture antibody was incubated at 4°C overnight.  
 The plate was washed with PBST, followed by rinse with PBS three times. 
  200 µL 3% BSA was added to the plate to block the portion of the surface 
that did not bind the capture antibody.  
 Incubated at 37°C for 1 hour.  
 After incubation the plate was washed with PBST, followed by a rinse with 
PBS three times. 
  300 µL CRP/DY647-αCRP solution was added in triplicate 
 Incubated at 37°C for 1 hour, and finally washed before measuring the 
fluorescence in the Tecan Infinite 200.  
2.5.2 Microfluidic Assay 
Following the same principle as the single step assay described in the previous 
section, the assay was transferred to the microfluidic platform that was developed 
as part of this work. 
2.5.2.1 Glass preparation 
For this experiment the substrate used is a standard microscope glass slide. The 
surface is functionalised with amine groups to promote a covalent bond with the 
capture antibody and the glass surface.  
 The glass was functionalised with a 3% APTES coating to generate amine 
groups on the surface. The amine groups allowed the capture antibody 
mixed with an oxidised dextran matrix to bind to the surface.  
 Capture antibody, C2 anti-CRP @ 200 µg/mL, was deposited within the 
detection zone of the micro-fluidic chip using the Scienion S3 micro-arrayer. 
The Scienion S3, a non-contact piezo dispensing system, generates 
microarrays with high accuracy and control on deposition patterns and 
volumes.  
 A 10 x 10 array, with a 500 µm pitch between each drop, was deposited 
within the channel of the chip. Each drop was ~500 pL, with the volume 
dictated by the 90 µm dispense capillary used.  
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Once deposited on the functionalised APTES surface, the capture antibody was 
allowed to incubate for 1 hour, at room temperature. Incubation was carried out in a 
humidity chamber to reduce the effect of evaporation and drying due to the small 
volumes deposited. After incubation, the surfaces were washed with PBS and 
blocked with 3% BSA for 1 hour at 37°C. The slides were washed again with PBS 
dried under a stream of compressed N2 and stored in a desiccator until required for 
experiments.  
2.5.2.2 CRP/ αCRP Solution Preparation 
Off chip, the different concentrations of CRP (Millipore/BBI group.) were prepared 
in CRP free plasma (AssayPro). To generate the curve from Figure 4.12, 
concentrations of 0, 0.1, 0.2, 0.5, 2.0, 10.0 and 20 mg/L were prepared. 5 µL of each 
concentration of CRP spiked plasma was mixed with 5 µL of the DY647 labelled α-
CRP (10 µg/mL) detection antibody. A separate chip was used for each 
concentration of CRP spiked plasma, with individual drops of capture antibody 
within the deposited 10x10 array providing replicates.  
10 µL of the CRP/ αCRP solution was loaded onto the chip and allowed to flow over 
the detection zone. As the sample required ≈ 10 minutes to flow through the chip, 
i.e. the incubation time is remarkably reduced from the usual 1 hour incubation at 
37°C. 
When the sample cleared the detection zone completely the PDMS portion of the 
chip was disassembled from the glass slide and disposed of. The glass slide was 
washed with PBST/PBS to remove any remaining CRP/ αCRP solution or unbound 
proteins that might have bound non-specifically and distort the final signal. The 
slide was then read using a Perkin Elmer ScanArrayGX.  
Chapter III 
Enabling Development of an Antibody Screening and 
Recovery Platform for Single Cell Manipulation within a 
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3.1 Introduction  
3.1.1 Hypothesis 
At present, state of the art for screening of antigen specific antibodies involves 
multiple panning steps of a large antibody library. With each cycle of panning, the 
number of candidate antibodies available for selection is reduced until a more 
manageable number is available for more specific characterisation. With all 
candidates within the library competing against one another, potential candidates 
are often overlooked and washed out due to weaker affinity or binding but this weak 
binding does not always constitute a less specific antibody. By segregating each 
antibody secreting cell into an individual micro-capillary, the library can be 
screened on a single cell basis, allowing an unbiased and highly specific interaction 
for each cell. By combining numerous micro-capillaries into a densely packed array, 
a high throughput, highly selective antibody selection tool could be realised.   
3.1.2 Rationale 
With antibody libraries potentially containing billions of potential ASC’s, identifying 
and retrieving the most antigen-specific using current technologies involve 
displaying the antibody on the surface of a phage (Bradbury et al. 2011) or cell 
(Horlick et al. 2013)and selecting the best candidates by affinity-based biopanning 
(Ehrlich et al. 2000) or fluorescence activated cell sorting (FACS)(Kruif et al. 1995). 
While techniques such as micro-engraving and microfluidic cell sorting have been 
developed for antibody discovery, they fall short in terms of their throughput, ability 
to screen both bacterial and mammalian cell and have limited multiplexing 
capability.  
Herein this chapter describes a novel process for screening antibody libraries, using 
high density glass micro-capillary arrays. The micro-capillaries are available with 
diameters as small as 5 µm up to several hundred µm. The work presented here 
utilises an array with diameter 40 µm, with 1 mm height holding 1.2 nL. The micro-
capillaries are bundled together in hexagonal groups with 45 µm pitch, centre to 
centre, and are open either end.  
It is proposed, that by loading the array with the cell/media solution diluted to the 
appropriate concentration, each micro-capillary would contain one cell only. The 
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loaded array would then be reversibly bonded to an antigen coated PDMS substrate, 
with the open ended micro-capillary allowing the secreted antibody within, to 
interact with the PDMS surface.  
(a) 
 
(b) 
 
 
(c) 
 
(d) 
 
(e) 
Figure 3.1 (a) 3D model of the micro-capillary array, not to scale. (b) Cross section model of an 
antibody secreting cell (ASC) with secreted antibody contained within a capillary, coupled to the 
PDMS surface. (c) Model of antibody/PDMS surface interaction with outline of micro-capillaries 
highlighted. (d) Scanned fluorescent image of the PDMS assay surface with each fluorescent dot 
representing the location of an ASC of interest. (e) Model with red dots highlighting the capillaries 
of interest and the randomness at which they happen. To translate or map (d) to (e) posed a 
significant challenge, with little indication of orientation relating the image to the array. 
Once removed from the array, the PDMS surface would be coated with a 
fluorescently labelled secondary antibody, which when viewed under a fluorescent 
microscope would reveal where the specific ASC’s from the array interacted with the 
PDMS surface. The resulting image of the fluorescent dots upon the PDMS surface, 
would essential provide a map of the corresponding micro-capillary within the 
array. The contents of each micro-capillary would then be retrieved into a standard 
microtiter plate for further analysis.  
  
? 
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3.1.3 Challenges 
 
To realise the potential of this new technology, two key challenges within the 
process were identified to enable its development and will be discussed in this 
chapter.  
1. The initial challenge in the process was to align the assay pattern from the 
PDMS surface with the micro-capillary array, providing a map of the 
locations of the ASC’s of interest within the physical array.  
2. With the locations of the ASC’s now mapped to the micro-capillary array, a 
method of retrieving the extremely small volumes from a single micro-
capillary was the next challenge addressed.  
By addressing the challenges above, the technology would be able to progress 
towards a high throughput antibody screening process as describes in Figure 3.2 
below.  
  
Assay 
  
Pattern 
  
Align 
 
Recovery 
⍰ 
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Figure 3.2 Graphical representation of the DiCAST process. (1) The array, loaded with the antibody 
library is reversibly bonded to the PDMS substrate to perform the assay. The PDMS seals the bottom of 
the array, effectively forming a micro well plate with millions of wells. (2) Incubation allows the clones 
to replicate and antibody is secreted, binding to the antigen coated on the PDMS substrate. (3) Post 
incubation the array is removed and stored while the PDMS substrate is analysed, to identify the 
positive clones. (4) The analysis provides the “map” with which the recovery system can locate the 
positive clones in the array and remove them into a 384 well plate for culturing 
Linking the scanned image or map of the assay surface to the custom built recovery 
platform and software, allowed the realisation of a new disruptive antibody 
selection technology. This chapter describes some of the challenges in implementing 
this technology and the strategies to overcome those challenges. 
3.2 Aligning Pattern on PDMS Surface to Micro-capillary 
Array  
As described previously in Figure 3.1, the screening process performs a fluorescent 
linked immunosorbent assay (FLISA) within a sub-nanolitre micro-capillary array. 
Each cell can be spatially addressed in an individual capillary. The secreted antibody 
which is specific to the antigen is then detected on the removable PDMS assay 
surface. The assay protocol was developed and optimised within the research team 
by Dr. Paul Leonard and Ms. Valerie Fitzgerald, both of whom co-invented this new 
screening technology along with Dr. Ivan Dimov and Prof. Richard O’Kennedy 
(WO/2012/007537).  
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Once the antibody library is loaded, each capillary captures a single cell. Based on a 
specific cell dilution, according to a Poisson distribution, each capillary will receive 
only one cell. The subsequent FLISA will be highly specific for the antigen of interest, 
and the antibodies highlighted as positive need to be removed from the array.  
Translating the FLISA result, (Figure 3.1 d) where the individual fluorescent dots 
correspond to a particular micro-capillary within the array, is the challenge 
presented and addressed in this section. 
 
    
 
   
    
 
   
The ability of the array to form a seal with the PDMS surface is crucial for the 
technology to function and any potential solution must not interfere with the 
planarity of that polished surface. With only 5 µm separating each capillary edge to 
edge, the resolution and accuracy of any potential solution had to be considered. The 
fundamental advantage of using the arrays was due to the density of the micro-
capillaries, therefore maintaining the integrity of the bulk of micro-capillaries was a 
major design consideration. 
Any implemented solution must be transferrable to the PDMS surface while 
remaining intact on the array for the duration of the process, so the resulting image 
of the PDMS can be correlated to the array.  
Taking inspiration from the assay process, where each micro-capillary can provide a 
fluorescent dot on the PDMS surface, the concept of sacrificing a number of 
capillaries to transfer a specific pattern to the PDMS was devised and developed.  
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3.2.1 Concept Design and Considerations 
To achieve the transfer of a pattern of specific capillaries, a strategy to block or 
sacrifice specific capillaries was designed. The main considerations in relation to 
implementing this strategy were: 
 Minimising the number a sacrificed capillaries so as not to jeopardise the 
number of cells that can be screened at any time 
 Maintain the planar surface of the array so as not to affect the sealing with 
the PDMS assay surface 
 Ensure the blocked capillaries remain blocked for at least the duration of 
the assay process 
 In tandem with mapping the locations identified from the PDMS surface, 
incorporation of a reference for orientation of the array was also required.  
(a)
 
(b) 
 
(c) 
 
Figure 3.3 (a) A select pattern of capillaries are blocked. (b) The surrounding capillaries are then filled 
with a fluorescent control solution, similar to that use in the assay, and the array is sealed to the PDMS 
surface (c) Once the assay is complete and the array is removed from the PDMS surface, with the 
pattern of the blocked capillaries transferred to the PDMS.  
It was envisaged that a particular pattern of capillaries in each corner of the array 
would be blocked or sealed, and while performing the assay a fluorescently labelled 
positive control would be added to the locations of these patterns. The capillaries 
that were intentionally blocked would not allow the fluorescent control pass 
through that capillary, meaning the resulting image on the PDMS surface would 
retain the outline of those blocked capillaries (Figure 3.1 c). 
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Figure 3.4 Reference marks are placed in each 
corner of the array. The capillaries of interest 
(highlighted red) can be located using the pixel co-
ordinates from the scanned image. The recovery 
system then locates the capillary and removes its 
contents. 
The patterns would serve two purposes. Firstly, they would provide a reference 
point in each of the corners of the array where individual capillaries within the array 
could then be triangulated. Secondly, the pattern should allow the user to readily 
identify the orientation of the array allowing no confusion once the array is 
uncoupled from the PDMS. It is possible that the array could become upturned, 
causing translations of the scanned PDMS image to the array to be incorrect and 
inverse to what they are intended to be. To accommodate this, a simple design 
inspired by a leading computer gaming console was utilised. By including, at the four 
points of a cross, a triangular arrow head to indicate the correct Y axis orientation, a 
square and circular arrowhead on the left and right extremes of the cross 
respectively, the orientation of the array at any point in time would be readily 
identifiable.  
 
 
Figure 3.5 An example of an early 
design used to pattern arrays.  
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Maintaining the three different shapes in the correct orientation ensured the array 
was maintained in its correct orientation.  
3.2.2 Experimental Approach 
Owing to the µm scale dimensions of the capillaries involved, standard fabrication 
approaches were not suitable. In addition, with the 1.0 mm thick glass capillaries 
being particularly brittle and difficult to machine using traditional fabrication 
methods, photolithography was identified as a potential solution.  
Photolithography is widely implemented as a fabrication method for 
microelectronic, microfluidic and MEMS devices (Becker & Gärtner 2008). A light 
sensitive polymer in liquid form is deposited onto a flat substrate, typically a 
circular silicon wafer or a glass substrate. Depending on the viscosity of the polymer, 
the height of the layer is controlled by depositing the material at the centre of the 
substrate and spinning at a pre-defined rpm. The speed relative to the viscosity 
provides a high degree of accuracy over the final height. Once the desired height is 
achieved, the polymer is exposed to a UV light through a patterned mask (Figure 3.6 
b). The mask is typically a glass plate with a metallic coating on one side. The 
metallic coating is patterned to allow the UV light pass through and cure the 
photoresist polymer. After exposure the polymer becomes cross-linked and bonded 
to the silicon/ glass substrate. The remaining photoresist can be removed by 
immersion in photoresist developer solvent. The cross-linked polymer is resistant to 
the developer solvent, therefore remains intact on the substrate.  
For this application we investigated filling capillaries with photoresist and 
subsequently curing a particular pattern Photo-resist is easily loaded into the 
capillary due to its fluid nature until it is exposed to ultra-violet light, where the 
polymer becomes cross-linked and bonds to the glass capillary. Two approaches 
using photoresist were investigated.  
3.2.2.1 Photolithographic Masking 
The initial approach implemented a photomask to expose the desired pattern within 
the capillaries. SU8 3010 by MicroChem Corp., USA, was the photoresist used for this 
application. SU8 3010 is a negative photoresist, and as described in Figure 3.6, upon 
exposure a negative photoresist will become cross-linked. Specified for features of < 
20 µm and coupled with its low viscosity of 340cSt, SU8 3010 was chosen. A drop of 
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photoresist was deposited in each corner of the micro-capillary array aligned with 
the locations of the patterns upon the photomask. With the array sealed by a block 
of degassed PDMS on one side, the photoresist was encouraged to penetrate the 
capillaries by taking advantage of the suction effect delivered by the PDMS when re-
introduced to normal atmospheric conditions from a vacuum environment.  
A glass slide coated with approximately 100 nm of gold was patterned as shown in 
Figure 3.7 (a). Using a 248 nm excimer laser with a 30 µm aperture, the pattern 
described was traced on the gold surface. The 30 µm aperture ablated a line 30 µm 
in width which was designed and drawn using AutoCAD. 
 
Figure 3.6 Photolithography process steps. (a) Photoresist is placed upon the array and penetrates the 
capillaries. (b) Custom fabricated gold photomask is positioned over the array and exposed to UV light 
source. (c) Following exposure the array is immersed in photoresist developer/solvent. At this point 
the photoresist that was exposed to the UV light is cross-linked, solidified and bonded to the glass 
capillary. The unexposed photoresist is “developed” away (d), leaving a replica of the pattern from the 
photomask in the capillaries. 
 
By design, with a 30 µm aperture it was intended that the ablated feature on the 
mask would align with a single capillary on the array, due to each capillary having a 
40 µm diameter.  
However Figure 3.7 demonstrates that while the approach described can produce a 
defined pattern of capillaries, the resulting transfer of that pattern to the PDMS 
surface does not produce a well-defined pattern.  
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(a) 
 
(b) 
 
(c) 
 
(d) 
 
Figure 3.7 (a) Gold mask imaged under microscope. The dark portion of the image is the gold layer with 
the ablated crosshair allowing light to pass through from the light source below. (b) After UV exposure 
and developing, the cross-linked photoresist are visible within the capillaries. (c) The resulting 
fluorescent image with a vague outline of the pattern from the array.  
The approach of adding a layer of photoresist to the surface of the array followed by 
curing that layer in a particular pattern proved successful to a point. The first 
drawback was the resulting modification to the planarity of the surface of the array. 
By adding even the slightest layer to the highly polished surface, in some cases the 
array was unable to seal with the PDMS surface and allowed leaking between the 
individual capillaries. The resulting pattern was unidentifiable and therefore 
unsuitable for the purpose of alignment. 
Removal of uncured photoresist from capillaries outside of the desired pattern also 
proved troublesome. Due to the high aspect ratio of the capillary diameter to length, 
penetrating the full length of the capillary with photoresist developer was a difficult 
process and led to some capillaries remaining filled.  
During the UV exposure it is also suggested that photoresist in adjacent capillaries 
was being exposed in some instances. Due to the glass capillaries, diffracted UV light 
that passed through the photomask was able to propagate through the walls of the 
capillaries, thus curing the photoresist in some of the adjacent capillaries meaning it 
could not be removed during developing.  
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3.2.2.2 Polymer Masking  
To address the issue of photoresist being difficult to post process once added to the 
micro-capillaries, the approach was redesigned. It was proposed that only the 
capillaries that need to be filled receive photoresist.  The addition of a polymer layer 
to the top surface of the array followed by ablating an opening in that layer that 
corresponded to the micro-capillary underneath meant that when the photoresist 
was added only that particular capillary was filled. By ablating a number of openings 
in a desired pattern it would be possible to accurately control the pores that receive 
the photoresist. Once cured, removal of the polymer mask would remove any excess 
photoresist, only leaving the pattern required. 
Positive Fluorescent Alignment 
The initial approach investigated here was to cut a square section of the polymer 
mask, while leaving a crosshair design intact within that bounding square. In doing 
so, the crosshair section would remain free of photoresist with the capillaries within 
the bounding square becoming filled with photoresist.  
When translated to the PDMS the crosshair alignment mark in each corner would be 
presented as a dark bounding square with a highlighted alignment  
(a) 
 
(b)
 
(c) 
 
Figure 3.8 Positive fluorescent masking and resulting fluorescent transfer upon PDMS surface.  
While this approach provided a very effective contrasting image where individual 
capillaries can be identified and located, sacrificing many capillaries was 
counterproductive to the high throughput nature of the antibody screening system. 
As described in Figure 3.8 each alignment sacrificed ~ 4000 capillaries with 
photoresist, not including the number of capillaries outside of the bounding square 
which were also filled with the control fluorescence. In the 23 mm x 23 mm array 
format there are some 260,000 micro-capillaries available. Using the design above, 
represented the sacrifice of at least 6.4% of available micro-capillaries within the 
array. To maximise the available area, an alternative and less wasteful design was 
required. 
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Negative Fluorescent Alignment 
The negative of what was previously described was proposed as an alternative, 
similar to the photo masking approach, where the crosshair design was filled with 
photoresist. The resulting transfer to the PDMS is a dark crosshair with orientation 
highlighted with the fluorescent control.  
(a)
 
(b)
 
(c) 
 
Figure 3.9 Negative fluorescent masking with resulting fluorescent transfer upon PDMS surface 
Ablating a 50 µm trace in the polymer mask, similar again to the photomask 
approach, allowed access to at least one micro-capillary along the trace. By applying 
photoresist upon the now penetrated polymer mask, the photoresist flows into the 
available capillaries only, and is exposed to UV light for curing within the capillary. 
Each crosshair occupies or sacrifices ~250 micro-capillaries, representing a total 
loss of 0.04% micro-capillaries upon the array. From Figure 3.10, at this point in the 
project, addition of the control fluorescence was performed manually, resulting in 
unnecessary wastage in terms of capillaries required. As highlighted in Figure 3.10 d 
& e, if a more controlled or automated system was used to dispense the control onto 
the array; it would only necessitate the application of control to the inner portion of 
the shapes providing the orientation information. This again would reduce the 
number of micro- capillaries sacrificed.  
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(a)
 
(b)
 
(d) 
(c)
 
(e) 
Figure 3.10 The finalised design and result of the chosen pattern. Top image of the physical array with 4 
alignment marks in each corner. (a) The full 23 x 23 mm array pattern with alignment marks in each 
each corner. (b) Microscope image of the SU8 within the array with (c), the resulting fluorescent 
transfer on PDMS. (d,e) A magnified view of the features of the pattern with distinctly individual 
capillaries.  
3.2.3 Results 
The performance of the alignment marks were monitored over a number of 
patterning sequences to get an indication of the effectiveness, robustness and 
reproducibility. Presented in Figure 3.10 and Figure 3.11 are the data for array 204. 
The number of open capillaries described in Figure 3.11 is a count of the number of 
capillaries bound by each of the shapes at each node of the cross hair. It represents 
the number of capillaries that should permit the fluorescent control to transfer to 
the PDMS surface. As such, each pattern should replicate the same number of 
capillaries on the PDMS as is represented in Figure 3.10 (a), an actual microscope 
image of the array.  
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(a) (b) 
Top Left Top Right 
 
  
  
Bottom Left  Bottom Right  
Figure 3.11 Array under microscope (a) showing the alignment marks in each corner and (b) the 
resulting fluorescent scanned image. 
To be regarded as a successful alignment pattern, a specific pattern that transferred 
to the PDMS must be readily identifiable upon the actual array. After manual 
inspection of the fluorescent image, the recovery instrument and hardware were 
used to identify the corresponding specific pattern chosen on the physical array. 
With those criteria in mind, a measure of the reproducibility of the pattern produced 
from each array was taken by comparing the physical array to the transferred image 
on the PDMS surface as tabulated in Figure 3.12.  
At present the loading of the control fluorescence and the application of the array to 
the PDMS surface is purely manual. As a result some errors occurred where the 
array did not completely seal to the array. From Figure 3.12, some experiments 
produced unusable results as a result of manual handling errors. In such cases the 
fluorescent image appears smudged and the identifiable marks unusable.  
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Top Left Top Right Bottom Left Bottom Right 
 
            
# of open 
capillaries 27 20 24 28 23 22 25 19 20 24 17 20 
Exp 1 29 22 24 28 24 23 25 19 20 24 17 20 
Exp 2 27 22 * 28 23 * * 17 * * * 20 
Exp 3 27 22 24 28 23 23 25 19 20 24 17 20 
Exp 4 27 22 24 27 23 24 * * * 24 17 19 
Exp 5 20 22 24 28 25 24 25 19 20 24 17 20 
Exp 6 20 22 24 27 24 24 * * 20 24 17 20 
Std Dev 3.95 0.00 9.80 0.52 0.82 9.65 13.6 9.58 10.3 9.80 6.94 0.41 
 
Figure 3.12 Reproducibitly and stability data of alignment experiments. The graph and table above 
report the number of patterned capillaries within each shape at each corner of the array. (* feature not 
readable due to smearing of pattern on PDMS) 
Taking each of the alignment orientation shapes as separate experiments, shows 
they perform robustly and reproducibly. It is proposed that any error introduced 
where the pattern does not transfer to the PDMS surface is a result of a handling 
error as the array is applied to the PDMS surface.  
3.2.4 Discussion 
Presented with the challenge of translating an identifiable and reproducible pattern 
from an almost random array of micro-capillaries, to an image which can be 
interrogated using machine vision software, described are the steps taken to achieve 
this by implementing common microfabrication techniques.  
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While initially successful, photoresist curing by using a photomask was somewhat 
uncontrollable in terms of the desired pattern. With diffraction through the walls of 
the glass capillaries cited as the main cause of curing in unwanted capillaries, the 
high level of control required to interrogate individual capillaries was not realised.  
Lasing access holes corresponding to individual capillaries in a thin polymer layer 
which covered the entire array, allowed precise and accurate delivery of photoresist 
to the capillaries required. No excess photoresist penetrated the surrounding 
capillaries, with the removal of the polymer tape layer post-process removing all the 
unwanted excess photoresist.  
Tracking the alignment marks over a number of experiments showed the 
photoresist to be stable over time. By observing the number of open capillaries 
bound by the different shape outlines, described in Figure 3.10, provided a baseline 
or control for the number of capillaries expected to be transferred during an 
experiment. The data presented in Figure 3.12 demonstrates the reproducibility of 
the process. However it also describes human error as being a cause of variation 
which would need to be addressed going forward. The manual nature of applying 
the array to the PDMS surface can introduce error and affect the sealing required. To 
address the error introduced by the manual application of the array to the PDMS 
surface would require the development of a high precision jig or high precision 
robotic system. Double movement of the array when placed in contact is the main 
source of error. With even the steadiest hand, precision of movement and control of 
movement cannot be guaranteed. As the overall DiCAST project was in the design 
and development phase, the focus was on developing a method of mapping the array 
to the recovery hardware. Even with this error present the system was able to 
develop, however for the DiCAST system to realise a commercial application a more 
robust system would be required. An array manipulation device would require 
resources that were beyond the scope of the project at the time of this work and 
should be developed to fully realise the reproducibility of this process.  
The process described allowed the successful mapping of the physical array to the 
alignment software and subsequently allowed for the cherry picking of individual 
capillaries by the recovery hardware.  
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3.3 Capillary Recovery Challenge 
 
     
 
  
     
 
  
Recovery of the identified capillaries for further analysis is the next challenge 
encountered.  A method by which a single cell of interest can be removed from an 
individual micro-capillary and recovered into a standard 384 well plate is described. 
The initial concept, designed and fabricated by Mr. Barry O’Donnell, implements a 
thin polymer layer reversibly sealed the top of the array, sealing the capillaries. A 
CO2 laser then ablates an opening in the polymer layer, at the location of a particular 
capillary as mapped from the scanned fluorescent image. As an opening is formed in 
the thin polymer layer, the laser shield gas of compressed N2 is applied to the 
contents of that capillary. As illustrated in Figure 3.13, all adjacent capillaries remain 
undisturbed as only the capillary of interest was targeted. The contents, under the 
force of the compressed N2, are collected below the array into a 384 well plate.  
 
Figure 3.13 Laser ablation recovery method explained (a) The array is loaded with the library to be 
screened. The array is then placed on a PDMS substrate. (b) A thin polymer film is place on the array 
to seal the contents during incubation and analysis. (c) Following analysis of the assay scan the 
locations of positive clones are identified. At the desired locations the CO2 laser ablates a small 
opening. This allows a stream of N2 to eject the contents of the capillary to the well plate below. As 
only individual capillaries are opened with each laser pulse only those contents are emptied into the 
well plate below. 
Thin Polymer film 
CO2 Laser & N2 Stream 
(a) 
(b) (c) 
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The application of a laser in the process was identified as a possible cause of damage 
to the delicate contents of the capillary. Forces generated by a laser pulse (Tagawa 
et al. 2012), followed by a blast of turbulent compressed N2, were identified as 
potential sources of stress for mammalian cells in particular. Also, by removing the 
laser from the process would simplify the process and eliminate a huge portion of 
cost when building subsequent systems.  
3.3.1 Micro-Air Jet  
Due to the capillary forces acting on the contents of each micro-capillary, once the 
cell suspension is loaded it will remain within the capillary until an external force 
acts upon it. Taking advantage of this and removing the polymer lid from the array, 
implementing a micro-air jet to remove the contents of single capillaries was 
investigated. The micro-air jet concept was designed to be highly focused and 
capable of interrogating single capillaries without disturbing neighbouring 
capillaries.  
This work involved the design and fabrication of a custom micro-air jet, and 
investigation thereafter of the removal of the contents from single micro-capillaries. 
 
Figure 3.14 Demonstration of air jet removing contents of an individual micro-capillary. 
3.3.1.1 Design and Fabrication 
The micro jet was designed to deliver a jet of compressed gas, N2 in this case, to the 
array. With this being one of the main considerations, the design had to consider any 
gas fittings required to couple the part to the compressed gas supply.  
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The main body of the device was fabricated with aluminium. 20 mm aluminium rod 
was turned on a lathe to produce the part as described in Figure 3.15 c. The function 
of this part in the device is to house the micro jet structure.  
The internal diameter of the micro-jet was cast within the aluminium body. 
Suspending a 25 µm tungsten wire centrally through the core of the aluminium 
housing, PDMS was poured and cast around the wire. 25 µm diameter was selected 
for the jet orifice to interrogate a 40 µm capillary. By aligning the jet orifice with the 
40 µm capillary and applying the compressed N2 to the orifice, the resulting jet of 
compressed N2 should eject the contents of the micro-capillary. 
The PDMS was cast around a narrowing at the nozzle end of the housing. As shown 
by the section drawing in Figure 3.15 d, the PDMS illustrated in green is anchored 
either side of the narrow section. This was intended to allow the application of high 
pressure to the 25 µm opening in the PDMS and eliminating the chance of having the 
PDMS ejected from the aluminium housing. Once the PDMS was baked and allowed 
to cure, the 25 µm tungsten wire was removed to leave the 25 µm opening through 
the centre of the PDMS.  
(a) 
 
(b) 
 
(c)
 
(d) 
 
Figure 3.15 Micro-jet design. (a) Image of finished part with 6mm push fit pneumatic fitting attached. 
(b) 3D model of aluminium housing with PDMS depicted in blue. 25µm orifice shown running along the 
centre line of the cylinder housing. (c) Schematic of aluminium housing with PDMS included for 
reference. (d) 3D cross section of the assembled aluminium and PDMS (25µm opening not to scale), 
with PDMS depicted in green. 
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The open end of the aluminium housing was threaded to ¼ -28 UNF. This allowed 
the coupling of the 6mm push-fit pneumatic fitting, for connection to the 
compressed N2.  
3.3.1.2 Proof of Concept Experimental Setup 
For initial testing of the concept of using a micro-jet to remove the contents of a 
single micro-capillary, as simple experimental rig was set up. This included 
fabrication of a manifold to hold and position the micro-jet device described 
previously. The manifold was 3D printed with guide holes to run along the optical 
post. This permitted no movement in the horizontal plane, while allowing the micro-
jet device to be moved in the vertical axis. From Figure 3.16, the array was place 
below the 3D printed manifold, and manually aligned so that once lowered the 
micro-jet orifice was aligned within the bounds of the micro-capillary array.  
(a) 
 
(b) 
 
 
Figure 3.16 (a) The experimental setup allowed movement in the Z axis, guided vertically 
along two optical posts. A valve for engaging the compressed air with pneumatic tubing 
connected (blue). The array is placed on the surface below the air jet housing. (b) Shows 
the air-jet assembled within the 3D printed housing. 
 
The manifold could be fixed at a certain position by 2 locking screws on each optical 
post. A locking screw was also used to loch the micro-jet device in position to avoid 
and unwanted movement. A manual gate valve was positioned inline on the 6 mm 
tubing, between the compressed gas regulator and the micro-jet device.  
3.3.1.3 Results 
Once the micro-jet was lowered into position and the micro-capillary array was 
manually positioned underneath, the gate valve was opened for ~ 2 seconds. The 
micro-jet was positioned manually, within several hundred microns of the array 
After closing the valve the array could be repositioned, and the valve opened again 
Micro-Air Jet 
Array 
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to eject the contents of another micro-capillary.  The array was imaged before and 
after ejection and the images were compared.  
Before 
 
After 
 
  
Figure 3.17 Food colouring loaded in an array, with before and after images following the interaction 
with the air jet. The images on top show single capillary evacuation. A cluster of 4 capillaries is shown 
to be evacuated possibly due to misalignment of the micro-jet to an individual capillary.  
With the lack of control for positioning and alignment of the micro-jet the micro-
capillaries, mixed results were achieved. While it was shown that the contents of 
single capillaries could be ejected while leaving the surrounding capillaries 
untouched, with misalignment, multiple capillaries were ejected in some instances. 
It is suggested if the micro-jet is misaligned and is applying the jet to the surface 
between two capillaries, it is likely that the contents of two or more capillaries, as a 
result of the deflection of the jet will be ejected or at least be disturbed. Also, due to 
the manual aspect of the movement and activation of the gate valve, some slight 
movements during the experiments contributed to some of the multiple capillary 
ejections.  
By introducing increased level of control of movement of the micro-jet and 
activation of the compressed N2, an improvement in performance was expected.  
3.3.2 Experimental Setup for Improved Control/ Accuracy  
To improve on the accuracy of alignment and introduce some control on the 
movement of the micro-jet, a multi axis platform was sourced to control the micro-
jet position and movement. With 0.025 µm resolution the xyz adjustment meant the 
nozzle could be moved incrementally and reproducibly to investigate whether 
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numerous capillaries could be interrogated in sequence. All movements were 
performed via micrometre adjustment on each access and each access could be 
adjusted independently.  
Keeping the array stationary, both the micro-jet and the microtiter plate below 
could be adjusted. A manual adjustment rig was fabricated for accurate movement 
of the microtiter plate below the array. The rig was set up for both a 96 and 384 well 
plates, with increments corresponding to each well location. Mounted upon the x 
and y axis of the translation stage, once a well position is selected the well plate 
moves with the micro-jet nozzle ensuring alignment between the micro jet, through 
the micro-capillary, and the well plate.  
The addition of a fine adjustment regulator allowed greater control over the 
pressure applied to the micro-jet nozzle. Along with the addition of a digital 
pressure gauge, this allowed incremental adjustment of the pressure to investigate 
the effect of different pressures applied. A three port/two position (3/2) pneumatic 
spring loaded push button valve was also added to the circuit between the regulator 
and the nozzle. Upon activation of the valve, pressure was applied to the nozzle. 
Once released the valve closed and any back pressure or latent pressure remaining 
in the line between the valve and the nozzle was allowed to exhaust through the 
open port to atmosphere. This design element was included to release any back 
pressure on the nozzle opening to reduce the possibility of interfering with other 
capillaries during subsequent movement of the nozzle relative to the array.  
  
Figure 3.18 XYZ stage with fine adjustment pressure regulator and 3/2 valve. The set up shown was 
implemented to demonstrate the ability to interrogate individual capillaries in a particular pattern. 
Each axis was independently adjustable.   
Figure 3.19 is the initial test carried out using the rig setup shown in Figure 3.18. By 
positioning the nozzle as close to the array as possible and activating the 3/2 valve, 
a capillary was emptied. From Figure 3.19 (a), after releasing the valve button, the 
3/2 
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XYZ Stage 
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nozzle was moved in the horizontal plane in set increments of 200 µm. The valve 
was activated once again and the next capillary was evacuated. In Figure 3.19 (b) 
the nozzle was adjusted in two directions, again in set increments of 200 µm. 
Before 
(a) 
 
(b) 
 
After 
  
Figure 3.19 Demonstration of single capillary evacuation with improved control. Before and after 
images of arrays loaded with food colouring, demonstrating that with greater control and the ability to 
locate specific capillaries, it is possible to empty that capillary using a small jet of air. 
With the manual nature of the position of the nozzle relative to each capillary some 
error is demonstrated, especially in relation to the post evacuation image of 3.19 
(b). Where the nozzle becomes misaligned between two or possible more 
capillaries, multiple capillaries were evacuated.  
For positioning of the well plate, a manual positioning stage was fabricated to adjust 
and position the well plate. The well plate position was adjustable relative to the tip 
of the nozzle, but once a position was chosen any movement of the micro-jet nozzle 
moved the well plate also. The manual stage was designed to accommodate each 
with increments for a 96-well plate or a 384-well plate. With the array held in a 
stationary position  
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Figure 3.20 Image of the final pneumatic setup including a digital pressure gauge, and the manual x/y 
positioner for a microtiter plate showing (right)the alphabetical increments and numerical increments 
for 96 and 384-well plates.  
3.3.2.1 Results:  
Bacteria Cell Recoveries 
With the proof of concept demonstrated, the challenge now was to load and array 
with bacteria cells and attempt to recover them using the micro-jet. Bacteria cells 
were chosen as the initial subject for experiments as they are more suitable for 
recovery. Bacteria cells are more robust against external forces, and even small 
numbers of recovered cells will propagate and grow if recovered into media. A 40 
µm diameter capillary array was used for all the following experiments 
Experiment 1 
In this instance the array was loaded with two different concentrations of bacteria 
cells. The concentrations used were 2x105/10 µL and 1x105/10 µL. 50 µL of each cell 
suspension was added at different locations within the array. 175 µL PBS was added 
to each well of the 96-well plate.  
For the experiment described in Figure 3.21, a constant 6 bar pressure was applied 
to the micro-jet upon activation of the push button valve. Manually, each burst 
applied to the micro-jet was timed at ~5 seconds. A 100µm increment in the X/Y 
plane was used to separate each recovery attempt.  
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A1 A2 A3 A4 A5 A6 A7 A8 A9 A10 A11 A12  
B1 B2 B3 B4 B5 B6 B7 B8 B9 B10 B11 B12 Non-Contact 
C1 C2 C3 C4 C5 C6 C7 C8 C9 C10 C11 C12  
D1 D2 D3 D4 D5 D6 D7 D8 D9 D10 D11 D12 Non-Contact 
E1 E2 E3 E4 E5 E6 E7 E8 E9 E10 E11 E12  
F1 F2 F3 F4 F5 F6 F7 F8 F9 F10 F11 F12 Non-Contact 
G1 G2 G3 G4 G5 G6 G7 G8 G9 G10 G11 G12  
H1 H2 H3 H4 H5 H6 H7 H8 H9 H10 H11 H12 Non-Contact 
Figure 3.21 Layout of 96-well plate for cell recoveries. Intended target wells are highlighted in blue, 
with the micro-jet/array interaction type highlighted in green for non-contact. 
Once the experiment was complete the plate was removed and viewed under 10X 
magnification using an inverted microscope. No cells were observed in any of the 
wells  
Experiment 2 
For this experiment the micro jet was used both in contact and non-contact with the 
array. Each concentration of cells was interrogated with both methods. With the 
non-contact method, as described in the proof of concept section, the micro-jet was 
moved incrementally by 100 µm in the X/Y plane between each evacuation. The Z 
height was maintained throughout.  
The contact method involved the micro-jet being lowered in the Z plane until in 
contact with the array. Once in contact the micro-jet was activated and the capillary 
below evacuated. The position at which the initial contact was made was recorded 
for subsequent contact evacuations. To move to the next position the micro-jet was 
retracted to a safe Z position before moving to seek the next capillary. Once 
repositioned above the next capillary the micro-jet was lowered to the previously 
recorded position to make contact with the array. This process was repeated as 
necessary for each recovery.  
A 40 µm diameter capillary array was used for all the following experiments. In this 
instance the array was loaded with two different concentrations of bacteria cells. 
The concentrations used were 5x105/50 µL and 7.75x105/10 µL. 50 µL of each cell 
suspension were added at different locations within the array. 200 µL PBS was 
added to each well of the 96-well plate.  
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A1 A2 A3 A4 A5 A6 A7 A8 A9 A10 A11 A12  
B1 B2 B3 B4 B5 B6 B7 B8 B9 B10 B11 B12 
Non-Contact 
5x105/50 µL 
C1 C2 C3 C4 C5 C6 C7 C8 C9 C10 C11 C12  
D1 D2 D3 D4 D5 D6 D7 D8 D9 D10 D11 D12 
Non-Contact 
7.75x105/10 µL 
E1 E2 E3 E4 E5 E6 E7 E8 E9 E10 E11 E12  
F1 F2 F3 F4 F5 F6 F7 F8 F9 F10 F11 F12 
Contact 
7.75x105/10 µL 
G1 G2 G3 G4 G5 G6 G7 G8 G9 G10 G11 G12  
H1 H2 H3 H4 H5 H6 H7 H8 H9 H10 H11 H12 
Contact 
5x105/50 µL 
Figure 3.22 Layout of 96-well plate for cell recoveries. Intended target wells are highlighted in blue, 
with the micro-jet/array interaction type highlighted in green for non-contact and yellow for contact. 
Cell concentrations are also outlined on the right. 
For the experiment described in Figure 3.22, a constant 4 bar pressure was applied 
to the micro-jet upon activation of the push button valve. Similarly to experiment 1 
previously, the plate was inspected using an inverted microscope at 10X 
magnification.  
Once again no cells were observed in any well within the well plate.  
Experiment 3 
A 40 µm diameter capillary array was used for all the following experiments. In this 
instance the array was loaded with two different concentrations of bacteria cells. 
The concentrations used were 2.5x105/50 µL and 5.0x104/50 µL. 50 µL of each cell 
suspension were added at different locations within the array. 200 µL PBS was 
added to each well of the 96-well plate.  
This experiment was set up to look at the effects of varying the pressure applied to 
the micro-jet. A series of pressures were tested including 2, 3, 5 and 6 bar pressure. 
Contact and non-contact interaction with the array were also investigated for each 
cell concentration and each pressure. At each location pressure was applied to the 
micro-jet for ~5 sec  
  
Chapter III: DiCAST 
58 
 1 2 3 4 5 6 7 8 9 10 11 12 Cell Conc. 
Array 
Interaction 
A  2bar  2bar  2bar  3bar   3bar   3bar  
2.5x105/50 
µL 
Non-Contact 
B  2bar  2bar  2bar  3bar   3bar   3bar  
5.0x104/50 
µL 
C  5bar   5bar   5bar   6bar   6bar   6bar  
2.5x105/50 
µL 
D  5bar   5bar   5bar   6bar   6bar   6bar  
5.0x104/50 
µL 
E  2bar  2bar  2bar  3bar   3bar   3bar  
2.5x105/50 
µL 
Contact 
F  2bar  2bar  2bar  3bar   3bar   3bar  
5.0x104/50 
µL 
G  5bar   5bar   5bar   6bar   6bar   6bar  
2.5x105/50 
µL 
H  5bar   5bar   5bar   6bar   6bar   6bar  
5.0x104/50 
µL 
Figure 3.23 Layout of 96-well plate for cell recoveries. Intended target wells are marked with the 
pressure applied to the micro-jet at that location, with the micro-jet/array interaction type highlighted 
in green for non-contact and yellow for contact.  
Upon inspection, under 10X magnification, 2 cells were observed in wells A8 and G6.  
Experiment 4:  
Once again a 40 µm diameter capillary array was used for the following experiment. 
In this instance the array was loaded with a single concentration of bacteria cells. 
The concentration used was 2.0x104/50 µL. 50 µL of the cell suspension was added 
to the array. 200 µL PBS was added to each well of the 96-well plate.  
Here, the effects of changing the pulse applied to the micro-jet were investigated. 
This was done by manually adjusting the duration and number of pulses at each 
location. See Figure 3.24. All recovery attempts for this experiment were 
implemented with the micro-jet in contact with the array. 
A1 A2 A3 A4 A5 A6 A7 A8 A9 A10 A11 A12  
B1 4bar B3 4bar B5 4bar B7 4bar B9 4bar B11 4bar Contact 
C1 C2 C3 C4 C5 C6 C7 C8 C9 C10 C11 C12  
D1 5bar D3 5bar D5 5bar D7 5bar D9 5bar D11 5bar Contact 
E1 E2 E3 E4 E5 E6 E7 E8 E9 E10 E11 E12  
F1 4bar F3 4bar F5 4bar F7 4bar F9 4bar F11 4bar Contact 
G1 G2 G3 G4 G5 G6 G7 G8 G9 G10 G11 G12  
H1 5bar H3 5bar H5 5bar H7 5bar H9 5bar H11 5bar Contact 
Figure 3.24 Layout of 96-well plate for cell recoveries. Intended target wells are highlighted in blue, 
with the micro-jet/array interaction type highlighted in yellow for contact. 
The pulse was varied as follows: 
 Row B:  short on/off pulses of valve 
 Row D:  longer pulse, ~10 seconds 
 Row F:   5X short on/off pulses at each location 
 Row H:  2X ~5second pulse at each location 
Chapter III: DiCAST 
59 
Following inspection of the plate post experiment, no cells were recorded as being 
present in any of the wells. 
Investigation of recovery effectiveness 
With less than favourable recoveries from the experiments reported it was planned 
to investigate the capture efficiency with the aim of quantifying the successful 
recovery of the contents of a micro-capillary.   
To achieve this it was proposed to load the array with horse radish peroxidase 
(HRP), and attempt to recover the contents of single capillaries into 
tetramethylbenzidine substrate (TMB) loaded in a well plate below the array. When 
mixed with HRP, an enzymatic reaction causes a colour change in TMB. The intensity 
of the colour change can be measured to give an indication of the amount of HRP 
recovered.  
Non-Contact Quantification Experiments 
A1 A2 A3 A4 A5 A6 A7 A8 A9 A10 A11 A12 
B1 B2 B3 B4 B5 B6 B7 B8 B9 B10 B11 B12 
C1 C2 C3 C4 C5 C6 C7 C8 C9 C10 C11 C12 
D1 D2 D3 D4 D5 D6 D7 D8 D9 D10 D11 D12 
E1 E2 E3 E4 E5 E6 E7 E8 E9 E10 E11 E12 
F1 F2 F3 F4 F5 F6 F7 F8 F9 F10 F11 F12 
G1 G2 G3 G4 G5 G6 G7 G8 G9 G10 G11 G12 
H1 H2 H3 H4 H5 H6 H7 H8 H9 H10 H11 H12 
 
Figure 3.25 Recovery of HRP into 96-well plate with TMB. Above describes the layout of the 96-well 
plate into which each evacuated capillary was directed. All evacuations were under 4 bar pressure.  
Figure 3.25 above shows the results for the application of 4 bar pressure to the 
micro jet with the table representing the location within the 96-well plate where the 
evacuated capillaries were directed. Each well contained 200 µL of TMB .For every 
location the micro-jet was repositioned to interrogate a new capillary by adjusting 
100 µm in the X or Y plane, and the push button valve was activated for ~ 2 sec. The 
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tip of the nozzle did not make contact with the array for this experiment, 
maintaining a minimum distance between the tip and the array surface. The 
minimum distance was set manually by visual inspection.  
 Excluding position E12, each positive recovery was achieved at the desired well. 17 
out of 24 intended wells show varying levels of recovery, demonstrating some loss 
of HRP during the evacuation of each capillary.  
In an attempt to increase the recovery of the contents of the capillary the pressure 
applied to the nozzle was increased. A comparison of a low and high pressure was 
performed using the previous 4 bar and an increased 6 bar pressure. Using the same 
template as before, 24 wells were selected upon the 96-well plate into which a single 
shot from the micro-jet was directed. Once again the micro-jet was being aimed 
blindly, with the intention of capturing the minimum number of capillaries. 
A1 A2 A3 A4 A5 A6 A7 A8 A9 A10 A11 A12 
B1 B2 B3 B4 B5 B6 B7 B8 B9 B10 B11 B12 
C1 C2 C3 C4 C5 C6 C7 C8 C9 C10 C11 C12 
D1 D2 D3 D4 D5 D6 D7 D8 D9 D10 D11 D12 
E1 E2 E3 E4 E5 E6 E7 E8 E9 E10 E11 E12 
F1 F2 F3 F4 F5 F6 F7 F8 F9 F10 F11 F12 
G1 G2 G3 G4 G5 G6 G7 G8 G9 G10 G11 G12 
H1 H2 H3 H4 H5 H6 H7 H8 H9 H10 H11 H12 
 
Figure 3.26 Recovery of HRP into 96-well plate with TMB. Rows A and C were subjected to 4 bar 
through the micro-jet with rows E and G having 6 bar applied. The results described were achieved 
with non-contact interaction with array 
Similarly to the previous non-contact experiment, each well contained 200 µL TMB. 
Each capillary recovery attempt was adjusted by 100 µm increments.  
The results shown in Figure 3.26 once again indicate that, while some wells do show 
recovery of HRP and were intended as target wells, only 11 of the 24 targets 
demonstrate recovery.  
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Figure 3.27 Non-contact recovery of HRP into 96-well plate containing TMB.  
Contact Quantification Experiments  
With the aim of trying to eliminate any loss of HRP during, the following experiment 
investigated interrogating each capillary with the micro-jet in contact with the array. 
The contact between the PDMS surface of the micro-jet and the array was intended 
to seal the jet orifice to the capillary of interest. Again, capillaries were chosen 
blindly at this point. 
 
 
Figure 3.28 HRP recoveries into a 96-well plate  
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All HRP data show that, while emptying the capillaries of interest, reproducible and 
consistent recovery of the capillary contents is erratic. 
Alignment of jet to capillaries factor, air jet evaporating contents, turbulence on 
under side of the array to be discussed 
3.3.3  Discussion 
Upon showing that a single capillary can be interrogated, the subsequent recovery of 
the contents proved elusive. Even with the primitive controls and equipment single 
capillary manipulation is possible.  
The extremely sporadic results shown with the attempted cell recoveries 
demonstrates that, while the contents might well be forced out of the array, it does 
not continue in a linear trajectory for collection. Albeit they describe a liquid jet, 
Acero et al show that, with the aid of a co flowing fluid stream they can control and 
extend the focus of the resulting jet (Acero et al. 2012). A method such as this would 
be difficult to implement with gases, like compressed air and N2 for example having 
similar densities. The similar densities would result in the diffusion of the two into 
one stream. The co-flowing stream would also interfere with the surrounding 
capillaries. Chang et al have reported that the surface tension on the underside of a 
nozzle, or in this case the underside of the array, can be significant and could cause 
the contents to spread along the bottom of the array (Chang et al. 2012).  
It has also been hypothesised in the group that due to the extremely small volumes 
present, the contents could be diffused or vaporised under the jet of compressed N2. 
The HRP recovery experiments would suggest that some of the contents of the 
targeted capillaries do in fact get collected in the well plate below, but as is evident 
with the low absorbance levels from graphs described in Section 3.3.2.1, the amount 
that does get collected varies greatly if collected at all.  
While demonstrating that a jet of air can move the contents of the micro-capillary, 
albeit with little control, new approaches to achieve recovery were required and 
pursued. Section 3.4 continues to develop a recovery solution of the micro-capillary 
contents by trying to reduce or eliminate the variability that the air jet results 
present.  
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3.4 Micro-Liquid Jet 
With the inconsistencies described by the air jet approach, a new concept was 
required. While the micro-jet concept was particularly simple in design, and 
compromise in simplicity and effectiveness was necessary. By selectively coupling a 
glass capillary to either side of the capillary of interest and passing a volume of 
liquid through that particular capillary , PBS in this case to maintain cell health, it 
was proposed that the capillary could be evacuated in a non-volatile way.  
 
Figure 3.29 Concept of coupling a glass nozzle either side of the array and flowing a liquid through a 
selected capillary to retrieve its contents. 
With the initial concept outlined troubleshooting of potential configurations that 
could be implemented was performed. In Table 3.1 each configuration is scored on 
different parameters that would impact its performance.  
As was the case with the non-contact micro-jet, a non-contact liquid was the 
configuration that scored the best. Achieving the best score in all but two of the nine 
categories, the non-contact approach would require a very fine jet of liquid to travel 
through the capillary, removing the contents of that capillary in the process and 
continue to jet out the bottom side of the capillary into the well plate below. The 
intricacies of implementing such a system would prove difficult. Similarly, the 
contact jet would appear to be one of leading solutions with the second best score. 
However, as was the case with the micro-air jet, surface tension on the bottom 
surface of the array was identified as a possible pitfall.  
The three least favourable options from the failure modes, effect and analysis 
involved some application of the laser process described previously when outlining 
Flow Direction 
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the capillary recovery challenge in Section 3.3 Capillary Recovery Challenge. Due the 
complexity of introducing the extra step of the lasing of holes in the polymer layer, 
all three options result with a poor score.  
After considering all conditions, and with the main aim to recover the contents of a 
single capillary in the most robust way, the “collected contact jet” was chosen as the 
most suitable configuration. Some issues surrounding contamination of the two 
glass capillaries were identified, although with adequate cleaning protocols in place 
it was suggested contamination could be eliminated.  
 
Table 3.1.Failure modes and effects analysis (FMEA) of potential liquid recovery configurations.  
Score each consideration: 
1= Good  
2= Neutral  
3= Bad 
Non-Contact Jet Contact Jet Collected Contact Jet Lasered Contact Jet  
Lasered Collected 
Contact Jet 
Lasered Non-Contact 
Jet 
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  % Liquid Loss 2 2 1 2 1 2 
Shear stress on pore 
contents 2 2 1 2 2 2 
Chance of contamination  1 2 3 1 1 1 
Throughput/ cycle time 1 2 2 3 3 3 
# of pores captured by jet 1 1 1 1 1 1 
ease of use/calibration 
effort 1 1 2 3 3 3 
simplicity of instrument 1 1 2 3 3 3 
reproducibility of 
instrument 1 1 2 2 2 2 
interference with 
alignment of the array 
through a cycle 1 3 3 3 3 2 
Total Risk Score 11 15 17 20 19 19 
Brief comments  Straight swap for the 
gas removal method. 
Quicker to adapt and 
make new 
instruments. 
Solves problems of 
affecting adjacent 
capillaries but may 
need a new wash step 
and is slightly slower 
with additional 
movements and could 
interfere with the 
array alignment 
Difficult to couple and 
align two tubes. Will 
likely affect the array 
alignment. 
Likely to affect array 
alignment. Increased 
stress on contents of 
capillary due to laser. 
Difficult to couple and 
align two tubes. Will 
likely affect the array 
alignment. Increased 
stress on contents of 
capillary due to laser. 
More stress applied 
to the one open 
capillary? Reduces 
chance of 
contamination. Likely 
introduce additional 
clean up step of the 
excess liquid 
gathering on the tape. 
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3.4.1 Proof of Concept 
To demonstrate the concept a simple rig was set up to couple two Tygon™ tubes either 
side of the array. The rig consisted of a top and bottom plate with two concentric holes of 
2.4 mm diameter to match the outer diameter of the tubing. The parts were cut using a CO2 
laser and were made from 2 mm acrylic. The two plates were separated by a spacer by 2 
mm to allow the array to be positioned between the two plates. The spacer was also cut 
from 2 mm acrylic using the CO2 laser. The top tube was connected to a Hamilton 250 µl 
gastight syringe which was driven by a Harvard Apparatus Syringe pump. The bottom 
tube was directed to a waste container or well plate if necessary.  
(a)
 
(b)
 
(c)
 
Figure 3.30 Proof of concept rig used to couple two tubes with the array. (a) shows a side profile of the two 
tubes aligned before the array is introduced. Image (b) shows the introduction of the array and (c) shows two 
seaparate recoveries from the array. Food colouring is used here to demonstrate the recovery of certain pores  
From Figure 3.30 the recovery of a particular portion of capillaries is shown. The oval 
shape of the recovery is due to the manual application of force to each tube to seal with the 
array. This application of force deformed the normally circular inner diameter of the 
silicon Tygon™ tubing. However it can be seen that the shape is well defined which would 
indicate the water passed through the tubing followed the path intended by coupling the 
tubing to the array. 
To further investigate the concept of coupling the array to two tubes either side, a new rig 
was designed. This second revision also used the 800 µm ID silicon tubing but removed 
the manual nature by which the tubing was coupled with the array.  
The main design element with this concept is the screw thread feed wheel. The thread on 
either side of the wheel is opposite to each other i.e. one is a left hand thread while the 
opposite thread is the standard right hand thread. When the wheel is rotated, as shown in 
Figure 3.31(a), the jaws of the rig move in opposite directions. This results in the jaws 
moving in opposite direction, bringing the tubing together or apart.  
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The jaws were 3D printed, with the opening for the tubing designed to provide a friction 
fit. The tight tolerances allowed the tubing maintain its circular profile when pressure was 
applied during coupling with the array.  
The feed wheel was turned on a lathe from 30 mm aluminium rod. The threads were hand 
cut using left and right hand M8 dies. The guide rod at the rear of the jaws acted as a guide 
to maintain the alignment. Due to the opposite threads the jaws tended to twist in 
opposite directions when the feed wheel was turned, thus requiring the need for the guide 
rod. The guide rod was machined using a lathe also, from 20mm aluminium rod.  
The frame which all components were attached to was cut using a CO2 laser. The material 
used was once again acrylic. The structure is formed in 3 sections, with the top and bottom 
section comprising 5 mm black acrylic. The middle spacer layer was cut from 6 mm clear 
acrylic, see Figure 3.31 (a) & (b).  
(a) 
 
(b) 
 
(c) 
 
(d) 
 
Figure 3.31 Revision of coupling mechanism for Tygon tubing to the array. (a) describes a 3D model of 
the apparatus with the jaws shown in wireframe for illustration. (b) demonstrates the assembled 
structure with the array in place between the jaws. (c) and (d) show close up images of the jaws in 
contact with the array.   
The results of experiments using this improved experimental rig are presented in Figure 
3.32 below.  
Feed Wheel 
Right hand thread 
Left hand thread 
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(a) 
 
(b) 
 
(c) 
 
Figure 3.32 Results from testing with rig from Figure 3.30. All images show the ID has been maintained 
and that the capillaries encompassed within the ID are recovered. 
Figure 3.32 demonstrates, using food colouring that the revised experimental rig allowed 
better control of the application of pressure to seal with the array. This resulted in good 
recovery of the food colouring. By flushing 100 µL of deionised water through the tubing 
and subsequently through the array, with a flow rate 200 µL/min, each of the experiments 
in Figure 3.32 show almost total clearance of the food colouring from the array. The waste 
was then collected in a petri dish below, with a diluted red colouring visible in the water.  
3.4.2 HRP Recovery to Investigate Efficiency 
To further look at the recovery efficiency, as before the array was loaded with HRP. Based 
on the area covered by the 800 µm ID of the tubing, 250 capillaries were targeted within 
the ID.  
With each capillary holding 1.2 nL, 250 capillaries represents 300 nL. Based on this 
assumption a dilution of 300 nL in 100 µL was used as a control. A dilution in 10 µL was 
also used for comparison. To achieve this, 300 µL of HRP was added to 100 mL of 
deionised water and mixed, taking 100 µL of this mixture to provide the 300 nL/100 µL 
control. In Figure 3.33 the control dilutions of 300 nL/100 µL and 300 nL/10 µL are 
loaded in wells B2 and E2 respectively.  
Wells B2-B6 and E2-E6 inclusive were initially loaded with 100 µL of TMB substrate 
before the addition of the controls. Wells B3-B6 inclusive were then loaded with a further 
100 µL of deionised water that was passed through the tubing and the array. The same 
process was repeated for wells E3-E6, except with a 10 µL volume of deionised water.  
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Figure 3.33 HRP recoveries with different dilutions. 
From the image opposite, well number 2 in both row 
B and E is a control. Wells 3-6 are actual recoveries of 
HRP from the array into the well plate.(rows G and H 
can be disregarded) 
Glass Capillary Coupling with Array Design and Fabrication  
With the concept demonstrated using a large ID tubing, the next challenge was to design a 
system capable of evacuating a single capillary. To that end, a device was designed using 
thick walled micro-bore tubing. With an outer diameter of 3 mm, inner diameters of 25 µm 
up to several hundred microns were available from Vitrocom Inc.  
For this experiment the upper of the feed capillary had a 25 µm ID. A 20 mm section of the 
300 mm rod supplied was cut with a ceramic grinding disk. Subsequently both ends were 
polished until flat and smooth, removing any scratches that occurred during machining.  
The finished section was then inserted to the custom made aluminium sleeve. The sleeve 
had an ID of 3mm also, with a tight tolerance relative to the glass capillary. A thin layer of 
Araldite epoxy resin glue was applied to the outer surface of the capillary. Once the glue 
was applied the capillary was inserted into the aluminium sleeve.  
The sleeve for the feed capillary had a counter bore hole at one end. The counter bore 
allowed a 10-32 UNF thread to be applied to this ID. The thread accommodated the fluidic 
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connections to couple the glass capillary to the syringe pump. As described in Methods 
2.1.4, the HPLC fluidic connection tightens a flat bottomed flange onto the flat end of the 
glass capillary, creating a high pressure seal and a continuous fluidic path from the PEEK 
tubing to the glass capillary   
For the collection capillary of 25, 75, 125, and 200 µm inner diameter were tested. All 
capillaries were tested by coupling the feed and collection capillary together and passing 
liquid through. The 200 µm capillary performed best thus was chosen for this experiment. 
The OD is the same at 3 mm with a 40 mm section length. The aluminium sleeve is almost 
identical, with the exception of the counter bore. The collection capillary remained open as 
it was directed to the well plate below. Therefore the fluidic connection is not required.  
  
Figure 3.34 3D models describing how the concept will be assemble. The white part in both images was 3D 
printed with the aluminium sleeves and capillaries aligned concentrically. The array is intended to be placed 
between the two capillaries. The green objects modelled are standard HPLC 10-32 UNF threaded connectors.  
Figure 3.34 describes the concept using 3D models. The physical objects are shown in 
Figure 3.35. The feed capillary can be seen in image (a) with the collection capillary shown 
in image (b). The fully assembled rig is then described in Figure 3.35 (c) and (d).  
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(a)
 
(b)
 
(c)
 
(d)
 
Figure 3.35 Images of liquid jet assembly. (a) Image of the feed capillary assembled within the aluminium 
sleeve. (b) Image of the collection capillary also assembled within its aluminium sleeve. The tip of both 
capillaries can be seen protruding from the sleeve. The open end of the collection capillary can be also 
seen protruding past the collar of the sleeve. (c) and (d) describe the assembled rig, with (c) including the 
array. 
As was the case with the air jet previously described, a pressure relief valve was included 
to relieve any back pressure on the system. It was observed that as the syringe pump 
delivered the required volume and stopped pumping, the latent pressure would remain 
and liquid would continue to be ejected from the capillary. The back pressure was not 
adequate to form a jet with the liquid tending to seep from the capillary and gather on the 
array. By including a valve that released any build-up of pressure, reduced to seeping post 
recovery.  
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3.4.3 Glass Capillary Cell Recoveries 
The results below show the recovery of cell from the array using the glass capillary 
concept from Figure 3.35. A cell concentration of 5 x 10-6 cells which according to a 
Poisson distribution should give ~5 cells per capillary. A 10 µL droplet of the cell 
suspension was pipetted onto the array in 2 different locations; see Figure 3.35 (c). The 
array was adjusted to align the first droplet of cell suspension with the glass capillaries. 
Once in position the array was lowered onto the collection capillary which remained fixed 
by means of a nylon retaining screw. The retaining screw tightened on the aluminium 
sleeve to maintain the position of the capillary.  
The feed capillary was then lowered onto the array. In theory the feed capillary was 
coupled with a single capillary within the array and the collection capillary. A limitation of 
this system was the inability to accurately align the two capillaries with the array 
capillary. With both capillaries in contact with the array, while maintaining a downward 
force on the feed capillary, the syringe pump was activated.  200 µL of filtered PBS was 
passed through the feed capillary with a flow rate of 400 µL/min and when aligned 
accurately, the PBS passed through the array and collection capillary and was collected in 
the well plate below.  
  
Figure 3.36 Cell recovery experiment 1 using micro-bore capillaries coupled to the array. A selection of the 
cells recovered are highlighted and amounted to 16 cells in total in the well. Images taken at 10X 
magnification. 
The results shown in Figure 3.36 show the successful recovery of cells by coupling two 
glass capillaries to the array. 16 cells were recovered in this experiment. 
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Figure 3.37 Cell recovery experiment 2 using micro-bore capillaries coupled to the array. A selection of 
the cells recovered are highlighted and amounted to 20 cells in total in the well. Images taken at 10X 
magnification. 
Experiment two from Figure 3.37 also demonstrates successful recovery of viable cells 
from the array. 20 cells were counted in the well post recovery. Once again this is higher 
than the expected ~5 cells per capillary based on the Poisson distribution. 
The excess number of cells recovered could be due to a number of factors. While the 
Poisson distribution suggests ~5 cells per capillary, the loading of the cell suspension into 
the array could introduce significant error. If the cell solution is not mixed well enough 
and the 10 µL droplet to be placed on the array is drawn from a portion of the suspension 
with an artificially high concentration, the number of cell per capillary may be higher than 
expected.  
It is also a possibility that due to the larger ID on the collection capillary, a number of the 
surrounding capillaries could be drawn into the well plate also. While the feed capillary 
should only target a single capillary due to its 25 µm ID, the 200 µm collection capillary 
will target at least 4 capillaries. As the liquid begins to flow through the collection capillary 
it is suggested that the surrounding capillaries could be evacuated also.  
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3.5 Discussion  
The body of work reported here is part of a wider effort to improve and enable the DiCAST 
technology as described in the Introduction and Background. DiCAST has the potential to 
revolutionise antibody and drug discovery technology and as such truly is a disruptive 
technology. By being able to assay each ASC individually and recover each cell with a high 
degree of accuracy is seen as critical to its success. 
As a concept the technology is simplistic. By placing each ASC within a “straw”, any 
potential targets would be identified and “blown” out of the straw. At 40 µm in diameter 
each and tightly packed into an array of hundreds of thousands of “straws”, recovery of the 
cells becomes a challenge. With the development of the alignment strategy, a method of 
mapping each capillary with high resolution accuracy was described. The permanent 
photoresist structure within the capillaries, allowed repeatable and reproducible results 
through which the assay surface could be mapped to the custom alignment software and 
recovery instrument. The alignment structures provided orientation and reference points 
to facilitate this mapping. The “map” could then translate each positive binding ASC from 
the assay surface to the capillary array, communicating with the recovery platform the 
precise location of each capillary to be recovered. The addition of the alignment structures 
facilitated the further development and realisation of the DiCAST platform.   
The use of a laser as part of the recovery system was identified as a possible source of 
stress upon the cells with the array. Reported here are two alternatives that remove the 
need for the use of a laser, thus removing the potential stress on the cells, any safety 
implications associated with the use of lasers and reducing the potential footprint of the 
final instrument. The micro air-jet was developed as the first alternative approach. By 
moulding a 25 µm orifice in PDMS, and forcing compressed N2 through the orifice a tiny jet 
of compressed N2 was formed. Initial results show that individual capillaries can be 
targeted and interrogated without disturbing the neighbouring capillaries, but 
reproducible and reliable recovery proved elusive. With such small volumes, evaporation 
and surface tension are suggested as two phenomena that hinder the recovery of calls 
from the capillaries by such a method.  
Following the discovery of the inconsistencies with the air-jet method, a liquid jet 
approach was investigated. Proof of concept experiments using large inner diameter 
tubing suggest the concept was feasible, demonstrating the recovery of bundles of 
adjacent capillaries. By designing and building a bespoke glass capillary recovery system, 
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it was demonstrated that by flowing a buffer solution through a single capillary and the 
contents of the capillary could be successfully collected. With similar inner diameters to 
that of the capillaries, the contents from an array were collected by coupling two glass 
capillaries to the array. The concept was based on reducing the stresses on the cells and 
removing the effects of evaporation and surface tension. As a result, the successful 
recovery of cells from within the capillaries was reported.  
Taking advantage of the open ended micro capillaries, DiCAST promises the ability to grow 
and recover cells individually and in a non-competing environment. Providing this 
environment for analysing individual cells will lead to greater specificity and extremely 
high through put of potentially millions of cells. By removing the need for traditional or 
more common single cell techniques such as micro-engraved micro-wells(Love et al. 2006; 
Frisk et al. 2011), micro fluidics (Grünberger et al. 2014; Zhu et al. 2012) and micro 
manipulators greatly increases the throughput of the DiCAST technology.  
Through the development of the alignment structures and alternative recovery methods, 
this work has helped advance the possibilities of DiCAST becoming a revolutionary new 
antibody selection tool.  
 
Chapter IV 
Whole Blood Cellular Fraction Extraction with Active 
Trapping (CLEAR) 
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4.1 Introduction 
As discussed in Chapter 1, the work of this thesis comprises two elements (i) contribution 
to the DiCAST project already described in Chapter 4 and (ii) work which contributed to 
an Enterprise Ireland commercialisation fund project, MobiMate, which aimed to design  a 
point-of-care fluorescence-based polymer microfluidic chip for detection of CRP, a marker 
for infectious disease, focusing initially on rheumatoid arthritis. The chip would take a 
blood sample, separate the plasma from the cellular constituents, direct the plasma to an 
assay region in the chip and perform a fluorescence-based assay which would be 
interrogated by a mobile phone.  The main elements which are the focus of this thesis are 
(a) the development of the novel blood separation chip and associated microfabrication 
and microfluidics (b) the integration of the assay chamber based on sample flow and (c) 
initial work on the assay with optical detection using a laboratory-based instrument.  
Because of ineffective and significant delays often involved with blood testing procedures, 
the POC blood testing market has experienced a significant boom in recent years. The 
vision is to enable testing in decentralised or non- expert /healthcare professional 
settings. This facility for accurate, remote health monitoring and testing will eliminate the 
need for frequent and inconvenient visits to the hospital, reducing costs and improving 
quality of care. This is the main motivation behind this project. 
4.2 SIMBAS Explained  
The starting point for the development of the blood separation element of the chip was the 
SIMBAS concept (Dimov et al. 2011) which uses degas-driven flow, which was developed 
as a method of separating plasma from a whole blood sample and achieving this without 
the need for external pumping or power requirements. In this work, the SIMBAS concept 
was further improved and modified as described below, and the second part of this work 
explored how this concept could be used to integrate a fluorescence-based immunoassay, 
using a whole blood sample directly from a finger prick, onto a modified SIMBAS-based 
chip for a point-of-care application. By removing red and white blood cells in this way, 
signal to noise ratio (SNR) is improved and the dependence on large bench top laboratory 
equipment e.g. centrifuges, is removed. For a conventional assay, carried out in the 
laboratory, the blood components are normally separated using centrifugation. The stand-
alone nature of degas driven flow, an integral part of the SIMBAS concept, removes the 
need for external pumping or actuation. The modified SIMBAS chip discussed in this 
Chapter is referred to here as CLEAR and is explained in the following sections. 
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4.2.1 Trench Filter Operation 
SIMBAS employs a trench as the filter for separating cells from the whole blood sample. 
Figure 4.1 demonstrates the principle of operation of the SIMBAS platform, showing the 
inlet channel for sample introduction, the trench filter for separation and the outlet 
channel from the trench filter for extraction of separated plasma. 
       Sample introduced                          Plasma extracted 
  
Figure 4.1 As the sample is introduced to the trench (a), the red blood cells (RBCs) tend to gravitate to the 
bottom of the trench. As the trench fills (b), the RBCs remain at the bottom of the trench and plasma occupies 
the top portion of the trench. Once the trench fills to the same height as the outlet, plasma is withdrawn, 
leaving behind the haematocrit portion of the whole blood sample.  Blue dashed line shows location of 
hydrophobic coating on the top surface the trench filter which assists the sedimentation of the RBCs 
By removing the chip from the low pressure of vacuum environment, the chip becomes 
active. As gas rushes back into the evacuated micro cavities of the porous PDMS, a negative 
pressure is generated in the channel of the chip to draw the sample through the channel 
network. Upon activation of the chip, a blood sample is place on the chip. The sample is 
transported to the trench filter via the inlet channel. At this point the hydrophobic coating 
o(e.g what material?) on the top surface of the trench filter restricts the flow of the sample 
across the top surface of the trench filter, forcing the sample to the bottom of the trench. 
As the trench fills with the whole blood, the cells sediment to the bottom of the trench 
filter, under gravitational force. With the cells accumulated on the bottom surface of the 
trench, a plasma layer forms in the upper section of the trench. As the trench filter reaches 
capacity, the plasma layer that has formed is extracted via the outlet channel, with the 
cellular components of the sample remaining in the trench.  Typical dimensions of the 
chip, as developed according to (Dimov et al. 2011), are 2 mm diameter x 2 mm depth 
with a channel of 50 µm x 250 µm.  
4.2.2 Limitations of SIMBAS 
Increase of the SNR for the assay is the main motivation for the removal of the cellular 
constituents from the whole blood sample. Also, removal of the large cellular components 
will reduce the likelihood of nonspecific binding or blocking of the capture sites, thus 
improving the assay signal further. Finally,   in the case of a fluorescence-based assay, clear 
plasma forms a more favourable assay medium by minimising optical scattering and 
intrinsic fluorescence of the cellular constituents.  
(a) (b) 
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While SIMBAS achieves this, the possibility of re-suspension of the cellular constituents is 
a major limitation of the technology. Separation is dependent on the platform remaining 
stationary and in a horizontal orientation. Should the platform be disturbed or agitated 
during the process, the separated cellular constituents would become re-suspended, re-
introducing them back into the plasma channel. These steps are illustrated below in Figure 
4.2. 
4.3 CLEAR Rationale and Implementation  
For CLEAR, cellular fraction extraction using active trapping, it was required to remove 
the sedimented cells from the trench to eliminate the possibility of interference with the 
assay. To achieve this, a novel active trapping system was designed, which builds on 
SIMBAS by providing a more robust method of managing sample constituents following 
separation. Specifically, this new approach makes use of the existing SIMBAS separation 
mechanism, i.e. gravitational sedimentation, implemented using a trench, but includes an 
additional channel at the base of the trench which is pumped under degas driven flow also. 
This facilitates active removal of particles from the base of the trench to a reservoir and 
significantly reduces the likelihood of re-suspension following movement of the chip.  
 
    
 
 
Figure 4.2 In a point of care 
application there is the possibility of 
the platform being disturbed by the 
user. Images (a-d) demonstrate the 
operation of the trench under normal, 
stationary conditions. Once the 
platform becomes disturbed (e) the 
cellular portion of the sample 
becomes re-suspended and can 
migrate to the plasma channel. 
(a) (b) (c) (d) 
Sample 
introduced Trench 
Vacuum pump section 
(e) 
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Figure 4.3 In the SIMBAS configuration, Figure 4.2 (e), the whole blood sample filled the trench from the 
bottom up. Once filled, the RBC’s remained in the bottom of the trench and could be re-suspended if agitated. 
For CLEAR a channel was added (c) at the bottom of the trench to remove the RBC’s to another location, 
removing the possibility of re-suspension into the plasma channel (b).  
However, with SIMBAS filling the trench from the bottom up, inclusion of the cellular 
fraction extraction channel at the base of the trench (Figure 4.3) would inhibit the ability 
of the trench to fill to capacity. In this configuration, the cellular fraction extraction 
channel would encourage the emptying of the trench before the plasma reached the upper 
extraction channel. 
4.3.1 Proof of Concept: Active Trapping of Beads Suspended in a Liquid 
Sample 
Figure 4.4 shows a schematic representation of a micro-fluidic chip that was fabricated to 
demonstrate the CLEAR concept. This chip comprised of a sample inlet channel of 1 mm x 
0.05 mm, a trench filter cylinder structure with 2  mm diameter and 2 mm height, and two 
outlet channels also 1 mm x 0.05 mm. The height of the channels is dictated by the 
thickness of the 0.05 mm PSA double sided tape. The two outlet channels were connected 
to a Harvard Apparatus Pico Plus syringe pump. A flow rate of 5 µl min-1 flow rate was 
controlled by the pump. A suspension of 20 µm polystyrene beads in water was used as a 
sample for the chip.  
Following introduction, the sample was transported to the trench filter and the beads 
were observed to sediment to the bottom of the trench filter. As the beads sedimented, 
they were sequestered to the outlet and away from the trench, reducing the likelihood of 
re-suspension into the top channel. Figure 4.4 shows a number of images obtained from 
the chip during these experiments. Figure 4.4(A) shows the beads at the bottom of the 
trench filter. Taken at 10X magnification this image is focused on the bottom surface of the 
trench showing sedimented beads. The channel leading to the outlet C can be seen at the 
right side of the image with direction of flow indicated by an arrow. With the water/beads 
suspension now separated, the water only portion is observed in Figure 4.4(B). Figure 
4.4(C) shows the outlet with the collection of beads that the active channel had 
sequestered from the trench filter to the outlet. While carrying out this test, it was 
(c) 
(b) (a) 
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observed that there was a tendency for the level of fluid in the chamber not to reach the 
top hence impeding the flow of plasma through the upper channel. This was the 
motivation for the inclusion of the sloped chamber in the final design. 
 
 
 
 
Figure 4.4 Detailed schematic illustration of micro-fluidic chip 
implementing the CLEAR proof of concept. Top Left: An exploded 
view of different layers. Above: Assembled 3D model. Right: Images 
from along the fluidic path, tagged with corresponding location 
from assembled chip. 
The particle suspension is introduced via the inlet, and passes 
through the trench filter (a). As the beads sediment the sample 
starts to separate. Beads that sediment are drawn away from the 
trench to outlet C, while the bead free solution remains at the top of 
the trench to be drawn to outlet B. Image (a) shows the particles 
settling to the bottom of the trench, (b) shows a clear liquid, with air 
bubbles visible at corresponding outlet B while (c) shows the 
particle solution at corresponding outlet C. 
 
4.3.2 Trench Modifications and Redesign 
To overcome the possibility of the trench not reaching capacity before the plasma portion 
is extracted, the CLEAR platform included a redesigned trench incorporating a slope at the 
entrance. As the whole blood sample enters the trench filter the sloped surface allows for 
gradual filling of the trench. The sample remained in contact with both the sloped surface 
and the top surface of the trench. This allowed the trench to fill uniformly and encouraged 
a laminar flow profile through the trench. This resulted in the upper and lower extraction 
channels being presented with the sample simultaneously, by which time the cellular 
constituents should be sedimented and therefore separated. Figure 4.5 demonstrates the 
sloped trench principle, where a number of angled slopes were tested. Once the sample 
a 
c 
B 
C 
b Sample Inlet  
A 
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reaches the end of the trench, the RBC’s are sedimented and the plasma is drawn off the 
top of the trench. The RBC’s are removed to a different location on chip so re-suspension 
cannot occur.  
(a) 
 
Figure 4.5 Modified trench schematic As 
the sample flows into the trench (a), the 
slope ensures that the sample maintains 
contact with the sloped surface of the 
trench and the top surface of the trench 
(b). As the sample continues to fill the 
trench the cellular components sediment 
(c), separating from the plasma. Finally, 
the sample is extracted from the trench (d) 
as separated plasma and the unwanted 
cellular components.  
(Direction of flow                  ).  
Image (e) is a side profile of a chip under 
flow, with the blood following the profile 
described in (a-d) above. 
(b) 
 
(c) 
 
(d) 
 
(e) 
 
Another consideration for implementing a slope is the effect on the flow profile of the 
blood sample as it transitioned from the micro-channel to the larger macro-scale trench. It 
has been reported that where the blood flow encounters a large step within a blood vessel, 
e.g. in an aneurysm, the flow is disturbed and a recirculating effect is observed at the near 
portion of the step (Skilbeck et al. 2004; Charoenphol et al. 2012; Hall & Calt 2014; Chiu & 
Chien 2011). This recirculating and turbulent effect, it is proposed, would inhibit the 
sedimentation of the RBC’s and hinder the successful extraction of plasma as a result. 
4.4 CLEAR Dual-layer Fabrication  
As described in Chapter 3: Methods, PDMS is typically moulded as a single layer, and 
where multiple layers are required numerous single layers are bonded together (Zhang et 
al. 2010; Wu et al. 2003; Wu & Lee 2013). Here is described a single step, two layer 
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fabrication process, whereby a dual layer micro-fluidic chip is fabricated in a single 
moulding step.  
4.4.1 Preparing the Master  
All channel structures were fabricated using a high precision double sided tape, ARcare® 
92712 (Adhesives Research Inc), with an overall height of 48 µm (± 2 µm). The tape was 
easily configurable and highly reproducible in terms of a controlled height and shape for 
channel construction and allowed for rapid prototyping. In comparison to typical 
photolithography processes, every iteration of channel design would necessitate a new 
mask, and subsequently a new silicon wafer master, the ARcare® 92712 double sided tape 
provided a quick and cost effective alternative.  
The channel structures were formed using a Graphtec RoboMaster Pro™(Graphtec 
America Inc.), which uses a knife to trace a profile on the ARcare® 92712. The trace 
profile is designed and drawn using AutoCAD software, see Figure 4.8. 
 
 
       PDMS  Channels and trench “via” 
Figure 4.6 Schematic representation of the moulding process. (a) Demonstrates how the channels 
(shown in red) are connected by the trench. The bottom channels are applied within a vessel. A 
transparent lid is then applied, carrying the top channel structure. The transparent lid allows the top 
and bottom channels to be aligned via the trench. PDMS is then poured into the mould and baked  
4.4.1.1 Pouring the Mould  
A 10:1 mixture of Dow Corning Sylgard 184 (PDMS), was prepared (Dow Corning 2007). 
The resulting mixture was then degassed, by centrifugation at 3000 rpm for 3 minutes, 
before pouring into the mould.  
As a result of the transparent acrylic lid, tiny air bubbles were observed when the PDMS 
was applied to the mould. Further degassing of the PDMS was required prior to baking 
because if allowed to remain, the air bubbles would expand during baking compromising 
the resulting channels.  
(a) 
 
(b) 
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At this point, the PDMS was baked at 65°C for > 4 hours. After baking, the mould was 
dismantled to remove the PDMS with resulting micro-fluidic channels now present. The 
channels were then inspected for any potential blockages and prepared for storage under 
vacuum until required for experiments. On occasion, some adhesive from the ARcare® 
92712 remained within the PDMS channels and needed to be removed.  
4.5 Optimisation of Flow Rate and Trench Dimensions 
For the optimisation of the flow rate, the microfluidic platform was divided into two 
sections; the trench and channels post trench.  
The trench dictated the volume of sample required for the chip to function as designed, 
but also was the structure within the platform where separation of the blood sample takes 
place. The channels post trench, including the degassed pump sections, dictated the flow 
rate and provided the capacity to receive and store the separated blood cells and plasma 
to avoid re-suspension or mixing of RBC’s back into the plasma sample.  
4.5.1 Trench Design 
As illustrated in Figure 4.5, the CLEAR trench was designed to take on a rectangular cross 
section and include the addition of a slope at the front end of the trench. To investigate the 
hypothesis of the redesigned CLEAR trench a number of trench configurations were 
trialled.  
The first key consideration looked at was the introduction of the trench and a number of 
angles were trialled, namely 40°, 50° and 60° slopes. Slopes less than 40° were too shallow 
and extended to far along the bottom surface of the trench, and therefore not investigated.  
The next consideration for the design of the trench is the total length, along which 
sedimentation of the cellular components is allowed to occur and as a result separation is 
observed. Increasing the length of the trench ultimately increases the volume of the 
trench, thus increasing the volume of sample required to fill the trench. If the sample 
available is inadequate to fill the trench, the limited sample will not be able to travel along 
the trench as described in Figure 4.3. Due to its ambition as a point-of-care platform, 
CLEAR is designed with a volume similar to that taken via finger prick, limiting the sample 
volume to ~35 µl or less. It was necessary that the capacity of the trench was less than that 
of the total volume of sample added, to allow the trench to reach capacity, without 
introducing air to the system before separation was realised. Volumes of 10, 12, 15 and 18 
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µl were trialled, equating to trench lengths of 3.75, 4.25, 5.00 and 7.00 mm respectively. It 
should be noted that as the slope angle altered the volume of the trench was also altered. 
However, as the resulting volume did not drastically alter the volume, it was not deemed 
critical to the operation of the trench. In all cases the height and width of the trench were 
constant at 2mm each. 
 
 Figure 4.7 Illustration of the redesigned trench 
wehre alterations to the angle of the slope, θ, 
and the overall length, L, were investigated. 
 
4.5.2 Degassed Pumped Section Considerations 
The flow rate for the platform was controlled by the cross sectional area of the pump 
section at the end of the channels post trench. By increasing or decreasing the area 
available to the channel, the flow rate, could be increased or decreased respectively. 
Figure 4.8 illustrates the different cross-sections tested for the plasma channel at the top 
exit of the trench. The channel dimension in each case was 600 µm leading to a degas 
pump section of different cross sections. Channel (b) from Figure 4.8 was implemented for 
the RBC channel, varying only the plasma flow rate. While separation was the main 
motivation, the performance of the chip was also determined by the time taken to 
complete a sample draw. Here is where a compromise between trench volume and flow 
rate were required.  
2mm 
θ° 
L (mm) 
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Figure 4.8 Three different channel dimensions used for the plasma 
extraction channel. In all cases the channel leading from the trench is 
600 µm x 50 µm, with different degas pump sections adjusting the flow 
rate. (a) 13x0.05 mm, (b) 10x0.05 mm, (c) 4x0.05 mm 
 
When separation is observed and the presence of plasma within the top channel on the 
chip, the channel is no longer visible under the camera used during experiments, due to 
the change in refractive index at the interface of the Zeonor and the PDMS surfaces. As 
seen in the pre/post images in Figure 4.9 below, with no plasma present the channel 
outline is clearly visible and once the plasma fills the channel is no longer visible.  
(a) 
 
(b) 
 
Figure 4.9 Image (a) shows the introduction of the whole blood sample with the trench almost filled. RBC’s are 
actively being drawn away from the trench to avoid re-suspension. In image (b) the trench has filled and the 
plasma (meandering) channel is drawing separated plasma from the trench while RBC’s continue to be 
segregated.  
Upon completion the channels and the trenches have completely emptied. From Figure 
4.10, the sample has passed fully through the trench and has move to the degas pump  
Leading edge 
of plasma
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section for storage and to ensure there is no chance of re-suspension of the cellular 
components back into the plasma portion of the sample.  
 
 
Figure 4.10 Image of chip post separation 
where the trench is completely emptied, 
with separate channel networks shown.  
4.6 Quantification of RBC Separation 
To quantify the effectiveness of the separation achieved, a selection of chips using the 
most suitable trench configuration as outlined in Figure 4.7 were tested. One blood sample 
was used for all chips. A cell concentration per mL was calculated using a hemocytometer 
to give an indication of the number of cells before separation was attempted. The blood 
sample was diluted to 1/1000 for the purpose of clarity while using the hemocytometer. 
The sample demonstrated normal levels of red blood cell concentration at 4.9 x109/ mL.  
The blood sample was then processed using four individual but identical CLEAR platforms. 
The separated plasma was removed from the chip for quantification of cell concentration / 
mL. A snapshot of the different chips showing the separate channels for RBC’s and plasma 
are displayed in Figure 4.11. The resulting cell concentrations of the separated plasma 
compared with the whole blood concentration are plotted and shown in Figure 4.11.  
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(a)
 
(b) 
 
(c) 
 
(d) 
 
 
Figure 4.11 Seaparation efficiency of CLEAR.  
Sample (a) performed the worst of all samples with sample (c) and (d) showing best 
performance.  
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4.7 Microfluidic Assay Application 
The ultimate objective of the CLEAR project was to separate a whole blood sample, 
capturing the blood cells on chip whilst simultaneously performing an on chip 
immunoassay on the separated plasma to determine the  C-reactive protein (CRP) levels in 
the sample. Dr Gemma Keegan (Zhang et al. 2015), Biomedical Diagnostics Institute, DCU, 
conducted all assay development and optimisation for eventual deployment on the CLEAR 
chip. In conjunction with Dr Keegan, we demonstrate the application of a fluorescence-
linked immunosorbent assay (FLISA), under flow conditions, using a similar chip to that 
outlined in the separation sections previously. By adapting a standard FLISA to mimick the 
conditions of an assay under flow, Dr Keegan was able to correlate the assay result under 
flow and account for the hook effect discussed in following sections. 
With time the largest constraint a compromise was reached to demonstrate the principle 
of a microfluidic FLISA using the CLEAR platform whereby elements of the assay were 
carried out off chip. The CRP assay was carried out under ‘normal’ traditional conditions in 
a 96 well plate to allow direct comparison and validation of the CRP assay before 
demonstrating the potential to perform the CRP assay under flow conditions on chip. 
Initially the assay was performed as a routine 2 step sandwich assay, which gave an 
indication of the dynamic range within which the assay was located and demonstrated 
that the antibodies were functioning as required A single step sandwich assay was then 
performed, also in a 96 well plate, to demonstrate the assay could in fact be carried out 
without the need for multiple wash phases. Finally the assay was performed under flow, as 
a single step sandwich assay.  
4.7.1 2-Step “Static” Sandwich Assay 
As is normal practice for a sandwich FLISA performed in a 96 well plate, a combination of 
individual incubation, blocking and washing steps are performed. The protocol is 
optimised and developed to provide optimal conditions for antibody/ antigen interaction, 
to give the best signal possible. Capture antibody is given adequate time and incubated at 
ideal conditions to promote binding to the surface of the plate. Thorough washing is 
performed post incubation to remove any unbound proteins that might alter the eventual 
signal. To occupy any parts of the surface that did not bind with capture antibody, the 
surface is blocked and incubated again at ideal conditions. The plate is washed again. 
Antigen is added to bind to the available antibodies on the surface, again being allowed to 
incubate under ideal conditions. Again the plate is washed to remove any excess, unbound 
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antigen. At this point the secondary detection antibody is added, allowed to incubate and 
finally the plate is washed once more. Each step is controlled and optimised for the best 
results. Excellent results are achieved using this approach but the disadvantages are that it 
takes hours to achieve a result and requires a skilled personnel to perform the testing. 
Because of ineffective and significant delays often involved with blood testing procedures, 
the POC blood testing market has experienced a significant boom in recent years. The 
vision is to enable testing in decentralised or non- expert /healthcare professional 
settings. This facility for accurate, remote health monitoring and testing will eliminate the 
need for frequent and inconvenient visits to the hospital, reducing costs and improving 
quality of care. Here we aim to correlate a standard on-plate FLISA and a single-step FLISA 
under flow using the CLEAR degas driven chip.  
The resulting assay curve is shown in Figure 4.12. The dynamic range obtained was 0.033–
2.5 mg/L.  
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Figure 4.12 Two-step sandwich assay, with multiple wash steps and 1 hour 
incubation times 
4.7.2 Single Step “Static” Sandwich Assay 
The single-step assay here refers to the simultaneous addition of the antigen and detection 
antibody to the assay. The single step sandwich assay was performed in identical fashion 
to the 2-step assay, in all but one step. Following a modified single-step protocol, the CRP 
dilutions were pre-mixed with the DY647-αCRP detection antibody. CRP was prepared as 
1
5⁄  dilutions of 50 µg/mL, while 10 µg/mL of DY647-αCRP was used.  
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CRP was successfully detected using the 1-step assay. Figure 4.13 shows that at higher 
concentrations of CRP the curve experiences a drop in fluorescent intensity, which is 
described as a “hook effect”.  
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Figure 4.13 One-step sandwich assay, demonstrated on plate 
where the hook effect is also evident 
4.7.3 Assay by Degas-Driven Flow – 1 Step Sandwich Assay 
An assay performed under flow requires the protocols described previously in this section 
to be modified. The channel structures of the chip now hold and incubate the sample as it 
flows through. From Section 2.4, the chip comprises of the PDMS channels and a rigid 
substrate to seal the channels.  
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Figure 4.14 One-step sandwich FLISA, carried out under flow, incubation time ~10 mins. (a) Schematic of 
the degas flow chip with mixing meander and detection zones. (b) Resulting assay plot form experiment 
shown at (c), demonstrating a significant drop in signal at the higher CRP concentrations, or a hook effect 
CRP was successfully detected under flow, but the hook effect reported in Figure 4.13 for 
the single step “static” ELISA, is again visible under “flow” conditions.  
4.7.4 Possible Causes of Decreased Signal or “Hook Effect” 
In the case of a standard FLISA protocol, the antigen and detection antibody are added to 
the 96 well plate separately, with a wash step in between. From Figure 4.15 (a), when the 
CRP is added to the assay it binds the capture antibody unimpeded. With increased 
concentrations of CRP, better coverage or a higher number of CRP can be expected. 
Therefore, the concentration of CRP determines the amount of bound detection antibody, 
resulting in increased signal with increased concentrations. At a point where there is total 
coverage, a saturation point is reached with no further increase in signal distinguishable.  
(a)
 
(b)
 
Figure 4.15 Possible cause of hook effect explained. (a) A typical sandwich assay protocol outlining 
different steps. (b) One step assay where both antigen and detection antibody are added together in 
one solution 
0 CRP, gain 65 5 CRP, gain 65 20 CRP, gain 
65 
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In the case of the assay performed under flow, Figure 4.14 (b), the CRP/ αCRP solution is 
added as a single solution at the same time point. While in solution the CRP and αCRP can 
interact immediately.  
At the lower concentration of CRP, the ratio of CRP: αCRP is high. With CRP’s pentameric 
structure, multiple αCRP detection antibodies can bind the CRP antigen, thus restricting its 
ability to bind to the capture antibody on the surface. Even with a lower incidence of CRP 
binding, the signal is artificially increased as a result of numerous αCRP antibodies per 
CRP. 
As the concentrations of CRP increase, the ratio of CRP: αCRP decreases, resulting in a 
reduction of the number of αCRP antibodies binding each CRP antigen. The result is a 
reduction in the overall signal irrespective of there being more CRP present. 
To overcome or negate some of the potential loss of diffusion as a result of the flow 
conditions, the capture antibody concentration was increased from 5 µg/mL to 200 
µg/mL. In doing so better coverage of the channel surface should be achieved thereby 
increasing the likelihood of binding the CRP as it flowed over the surface. In turn, the αCRP 
concentration was also increased, from 2.5 µg/mL to 10µg/mL. This was the same 
concentration used in the single step plate assay. Due to costs associated with the 
fluorescent dye and detection antibodies, higher concentrations were not achievable 
within the projects budget. It is possible that if the αCRP detection antibody were 
increased the hook effect could be compensated for and negated.  
4.7.5 Integrated 1 Step Microfluidic Assay  
As stated previously the objective of the CLEAR concept is the implementation of a single 
step assay on-chip and under flow. Some preliminary experiments were carried to out 
investigate the feasibility of lyophilising, or drying, the detection antibody within the 
channel of the chip, whereby the detection antibody would then be re-suspended as the 
sample flowed over. The detection antibody would then bind to the CRP in solution, prior 
to encountering the capture antibody further along the microfluidic channel.  
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(a) 
 
(b) 
 
Figure 4.16 Initial test using a straight channel did not allow sufficient time for re-suspension 
of reagents. Image (b) shows the reagents lyophilised at the beginning of the channel with no 
signal detected at the detection antibody site, depicted in the hatched area in image (a) 
Initial experiments with CRP spiked plasma, produced poor results. The straight channel 
did not provide sufficient time for re-suspension and diffusion at the assay site and limited 
binding occurred. See Figure 4.16. The lyophilised detection antibody can be seen on the 
left of the image 4.16 (b), with no binding occurring with the detection antibody at the 
location highlighted.  
4.7.5.1 Re-suspension of Lyophilised Reagents 
To aid re-suspension the channel was increased in length and a mixing region was added 
where the lyophilised labelled antibody was afforded time to re-suspend and diffuse in the 
plasma sample (Gervais & Delamarche 2009; Gervais et al. 2011). Once it reached the 
assay site, an increased signal was observed at the assay site. Comparing Figure 4.17 (b) 
with Figure 4.17 (b), a definite increase in signal is detected.  
(a) 
 
(b) 
 
(c) 
 
Figure 4.17 Schematic of the channel with increased channel length and mixing region (a) 
Owing to the fact that the project reached its conclusion no further optimisation and 
experiments were performed. A single step CRP assay under flow was successfully 
demonstrated on chip and preliminary optimisation for resuspension of lyophilised 
detection antibody was performed. While the concept was demonstrated using CRP free 
Mixing region 
Detection sites 
Lyophilised detection Ab 
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plasma spiked with CRP, it is proposed that a finger-prick of blood separated using the 
CLEAR platform would achieve the same result.  
4.8 Discussion 
Here we have demonstrated the successful transfer of a static FLISA CRP assay from a 
traditional 96 well plate format to a microfluidic chip with positive detection of CRP under 
flow conditions on-chip. In doing so we have reduced the time needed from several hours 
to a matter of minutes. Incubation is also performed in ~10 minutes and is carried out at 
room temperature.  
The hook effect is problematic and reduces the effective range of the assay. However, by 
demonstrating its presence in the normal plate conditions points to the issue being one of 
a protocol adjustment as opposed to the difference of flow compared to the static assay. 
With further investigation of the ratio of CRP:αCRP, it is suggested that the hook effect 
could be compensated for and the range of the assay extended. By increasing the amount 
of αCRP, a more uniform coverage or binding to CRP is predicted across the different 
concentration points.  
Also demonstrated is the potential for lyophilising αCRP within the channel. In doing so, 
the chip could be realised as a true point-of-care device. Only requiring the addition of the 
patients’ finger-prick sample of whole blood, the resulting separated plasma now activates 
and re-suspends the lyophilised αCRP. Given sufficient time for re-suspension by 
increasing channel length and the mixing effect of a meandering channel, αCRP re-
suspension was demonstrated.  
4.9 Summary 
It is hoped that the innovative design features of the CLEAR chip and the development 
work on the assay which has been reported in this chapter, demonstrates the potential of 
the concept for POC testing based on a pin-prick blood sample. It is unfortunate that time 
and project resource constraints have limited the progress that was achievable. Plans for 
future development of the concept are outlined in Chapter 5 of this thesis.  
 
Chapter V 
Conclusion and Future Work 
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Many results have been reported in this thesis with great potential. With the lifetime of the 
each project limiting the advancement of the respective technologies, much more work is 
needed to realise their full potential.  
The DiCAST platform has the potential to revolutionise the antibody production market 
due to the possibility of extremely high throughput. Demonstrating the ability to screen 
possibly millions of cells, individually and in parallel was made possible by development 
of the alignment technique described in this work. However some issues remain with 
reproducibility and inter-user variability.  With further development of a high precision 
array jig or robot, this variability could be addressed and removed.  
The air jet concept of micro-capillary interrogation showed great promise as a proof of 
concept. It demonstrated a capability of evacuating individual micro-capillaries without 
disturbing the surrounding capillaries or their contents. Further characterisation of the 
fluid dynamics, of both the air-jet and the contents of the capillary when ejected, could 
determine the feasibility of further developing this approach to evacuate each capillary.  
The air-jet nozzle, as reported here was fabricated in-house using a soft polymer. By 
redesigning and outsourcing the fabrication of the nozzle may also improve its 
performance. A highly toleranced, high precision focused glass nozzle could greatly 
improve performance.  
Similarly, the liquid-jet demonstrated great promise as a proof of concept design. The 
ability to align nozzles either side of the array was possibly the greatest limiting factor 
with the device described here. The liquid-jet demonstrates a distinct advantage over the 
air-jet concept by the recovery of cells from the array which proved elusive for the air-jet. 
By using a similar medium to which the cells were suspended within, is suggested as a  
more favourable method of recovery. Any issues with evaporation are removed from the 
process and if the alignment issue can be rectified, the collection of the contents can be 
readily achieved.  
Automation of the either the liquid or air-jet, is suggested as a logical next step to further 
remove any error by manual operation. With high precision control and adjustment of the 
jets coupled with a machine vision alignment system the concept could realise a much 
greater level of accuracy and control. 
The CLEAR platform, as a point of care platform has the potential to be deployed into 
remote and low resource environments for the monitoring of some disease states such as 
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rheumatoid arthritis and early detection of others like cardio vascular disease. This body 
of work has demonstrated the effective removal of the large cellular components of a 
whole blood sample using a platform fabricated for a fraction of the cost of the equipment 
required in a laboratory setting. Removal of these components allows optical detection of 
biomarkers within the sample which can lead to early diagnosis and/or treatment of many 
common disease states. That the platform does not require any external power or 
actuation means it could be deployed in extremely low resource environments or simply 
at the point of care situation in a GP setting for instance.  
To realise the potential of this application much work is required in terms of flow stability 
to ensure reproducible separation can be realised with each test. Characterisation of low 
pressure storage is required to investigate its effects on the device flow rate 
reproducibility.  
At the outset, it was hoped this thesis would report the selection of a specific antibody 
using the DiCAST technology and subsequently detect and quantify its presence in a buffer 
with a known concentration, using the CLEAR device. It was envisaged that the 
combination of DiCAST and CLEAR could be demonstrated as a personalised medicine 
approach where the specific antigen response from a patient could be characterised using 
the DiCAST platform. This characterisation would then be used to tailor the chemistry 
placed upon the CLEAR platform, providing a highly specific and patient specific response. 
This concept is possibly a number of projects in their own right. 
This body of work has successfully demonstrated many concepts to allow the 
development of potentially ground breaking disruptive technology. It is hoped that the 
work described here can be further developed as integral and necessary parts of the larger 
projects DiCAST and MobiMate.  
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